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Abstract
Bacteriophage lambda infection of Escherichia coli can result in distinct cell fate out-
comes: for example, some cells lyse while others survive as lysogens. A quantitative
molecular model of lambda infection supports the hypothesis that spontaneous dif-
ferences in the timing of individual molecular events during lambda infection leads
to variation in the selection of cell fates. Building from this analysis, the lambda
lysis-lysogeny decision now serves as a paradigm for how intrinsic biomolecular noise
can inﬂuence cellular behavior, drive developmental processes, and produce popula-
tion heterogeneity. The aim of this thesis is to re-evaluate lambda as a paradigm
for stochastic behavior by determining whether and to what extent variation in cell
fate selection results from pre-existing cell-cell diﬀerences rather than chance events
during infection. I ﬁnd that physical diﬀerences among cells present prior to infection
can control lambda developmental outcomes. Speciﬁcally, variation in cell volume
at the time of infection can be used to predict cell fate: small cells tend to produce
lysogens while larger cells favor lytic growth. I then present evidence that the appar-
ent sensitivity to host volume is encoded by components of the lambda regulatory
network acting upstream or at the level of CII, a critical regulator of the lambda
lysis-lysogeny decision. I also detail the construction and evaluation of new strains,
tools and methodology to size-fractionate populations of cells, to detect lambda in-
fection and gene expression at the single cell level, and to enumerate individual phage
particles. My results motivate further research to understand how and to what ex-
tent natural biological systems tolerate, buﬀer or correct for spontaneous molecular
variation during development in order to produce deterministic behavior.
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Title: Cabot Assistant Professor of Biological Engineering
Thesis Supervisor: Chris Kaiser
Title: MacVicar Professor of Biology
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Chapter 1
Introduction
Multi-cellular systems have the extraordinary ability to develop and diﬀerentiate,
giving rise to many specialized cell types. Cellular diﬀerentiation is typically highly
controlled, and is thus an exciting process with which to study how cells can inte-
grate information from their environment to direct their developmental response. Of
particular interest are the constraints that might limit the ability of cells to make ac-
curate developmental decisions. For example, commitment to a given cell fate must
typically be made within a limited time window and involves collecting environmen-
tal and internal cues which may be complex, ambiguous or ﬂuctuating. Given such
constraints, the reliability often observed in the development of natural biological
systems is remarkable [71]. For instance, the patterns of programmed death and
terminal diﬀerentiation during embryonic development of Caenorhabditis elegans are
nearly invariant from one individual to the next [162].
One particularly useful model system to study the properties of cell fate deci-
sion networks is bacteriophage lambda (λ), a 48,502 bp dsDNA virus that infects
the bacterium Escherichia coli [63, 98, 99]. Lambda-infected cells typically become
lytic or lysogenic. Cells that become lytic produce and release progeny phage into
the environment following lysis of the host cell. Alternatively, if infected cells be-
come lysogenic, the phage genome integrates into the bacterial chromosome and
the resulting prophage is passively replicated within the surviving cell and its oﬀ-
spring [63, 67, 110, 138]. The lysis-lysogeny regulatory network is one of the best-
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studied natural biological networks, giving the opportunity to study system-level
behaviors [2, 106, 119,154,176,181].
In this Chapter, I ﬁrst describe the cascade of events leading to commitment to
lytic growth or lysogeny. I next describe how the lambda regulatory network may
sense two important aspects of its environment: the nutritional status of the host cell
and the number of phage concurrently infecting a given cell. I conclude by describing
a puzzling observation that motivated my thesis research: genetically-identical cells,
infected by the same number of phage, do not always adopt the same cell fates, and
present two models that may explain this observation.
1.1 Timing of lambda gene expression during de-
velopment
The development of phage lambda is typically described as a cascade of gene expres-
sion divided into three stages. ‘Immediate-early’ genes are the ﬁrst to be expressed
after entry of phage DNA into the host cell. It is generally thought that lambda
does not commit to lytic growth or lysogeny during this stage. In the ‘delayed early’
phase, infected cells produce regulators of the lysis-lysogeny decision, and are thought
to commit to a given cell fate. Finally, in the ‘late’ stage of infection, lambda imple-
ments the developmental decision made in the ‘delayed early’ stage. Each of these
stages is now described in greater detail, and depicted in Figure 1-1 (p.21) and Figure
1-2 (p.22)
1.1.1 Immediate-early stage
See Figure 1-1a; p.21
Immediately after phage DNA entry into a cell, the strong promoters of the right (pR)
and left (pL) operons are active, driving expression of the regulators Cro and N, respec-
tively [42, 124, 146]. Expression of ‘delayed early’ genes, located downstream of N and
cro, is attenuated by transcriptional terminators located beyond these two genes [109,150].
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However, these terminators are not 100% eﬃcient, and so a limited amount of downstream
genes are also transcribed during the immediate-early stage. For example, tR1 is only ∼50%
eﬃcient [28], so that cII, O and P are transcribed to a certain degree. It is unclear to what
extent genes of the pL operon past the tL1 terminator, such as cIII, are expressed during
this initial phase of lambda infection.
1.1.2 Delayed-early stage
See Figure 1-1b; p.21
Eﬃcient expression of delayed-early genes, located downstream of the tL1 and tR1 termi-
nators, depends on a product from the immediate-early stage: the N protein [146]. Lambda
N is a transcriptional antiterminator that forms a complex with host factors, thereby allow-
ing RNA polymerase to overcome most lambda transcriptional terminators, including tL1
and tR1 [18,50,63]. N-mediated antitermination allows eﬃcient transcription of downstream
genes, both those participating in the lytic pathway (e.g., Q, replication and recombination
genes) and those involved in the establishment of lysogeny (cII, cIII) [77]. Finally, Cro
accumulates to suﬃcient levels to start repressing the pL and pR operons by binding to its
cognate operator sites [60], thus limiting further transcription of early genes.
Commitment to lytic growth or lysogeny is thought to occur at the delayed-early stage,
but the exact timing and mechanism of the lysis-lysogeny decision is still not completely
understood [67,130,138]. However, the activity of the delayed-early protein CII is thought
to be critical in determining cell fate: infected cells with high CII activity tend to become
lysogens, while those with low CII activity tend to follow the lytic pathway [7, 9, 17, 31,
63,67,87,130, 138] (see also later sections and Chapter 5). Another delayed-early product,
the CIII protein, is also thought to play a critical role in the lysis-lysogeny decision by
stabilizing CII [41].
1.1.3 Late stage
See Figure 1-1c,d; page 21
Cell fate selection, thought to occur predominantly during the delayed-early phase, is
implemented during the late stage. In cells slated to become lysogens, CII coordinates
19
the repression of lytic functions and the establishment of lysogeny by binding to three
promoters: paQ, pRE and pI [67, 130]. CII reduces transcription of the lytic gene Q by
binding to paQ, thereby promoting transcription of a small RNA antisense to Q message
and leading to lowering of Q expression [69, 159]. CII also leads to repression of lytic
functions indirectly, by driving expression of the lambda repressor (CI) [142]. In turn,
CI turns oﬀ lytic functions (as well as cII expression) by binding to its cognate operator
sites within pR and pL [117,120,121]. Moreover, by binding to the right and left operator
regions, CI can activate its own expression from the pRM promoter [121], thus ensuring
maintenance of lysogeny. Finally, CII drives expression of the lambda integrase by binding
to pI [129], ultimately leading to site-speciﬁc integration of lambda DNA into the host
chromosome [57,99,175].
For cells that select the lytic pathway, CII expression is presumably not high enough
to repress Q, another phage-encoded antiterminator. Q, a phage-encoded antiterminator,
allows transcription from the constitutive pR’ promoter to extend past the tR’ terminator,
leading to expression of genes involved in capsid formation (e.g. D, J ), DNA packaging
(e.g. A) and lysis of the host cell (R, S) [50, 63, 68, 166]. A threshold requirement for
Q antitermination function has been posited to explain why there is a delay between the
accumulation of Q protein and the observation of Q-mediated antitermination [88].
1.2 Environmental regulation of the lysis-lysogeny
decision
1.2.1 Regulation of the lysis-lysogeny decision by the nutri-
tional conditions of the host cell
Growth condition of the host can directly impact the lambda lysis-lysogeny decision. For
example, cell fate statistics vary with the growth phase of the host cells at the time of
infection (Figure 1-3, page 23). Moreover, starvation of host cells prior to infection has
been shown to raise the probability of lysogeny [92, 105]. How lambda infected cells sense
and respond to growth conditions remains poorly understood. In this section, I describe
how host-encoded factors may couple the growth rate (or nutritional status) of the host cell
20
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Figure 1-1: Stages of lambda gene expression during infection. a, immediate
early gene expression. b, delayed early gene expression c, late lysogenic gene expres-
sion d, late lytic gene expression. Arrows indicate positive interactions, bars indicate
negative interactions. Brown boxes indicate promoters, pink stop signals depict ter-
minators and yellow circles represent genes and corresponding gene products. Not all
interactions or components are depicted. A composite of subﬁgures a-d is shown in
Figure 1-2 (page 22). This ﬁgure was inspired in part by Figure 6 of ref [130].
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Figure 1-2: Timing of lambda gene expression during infection. The color
of arrows and bars indicate the stage of lambda infection at which the interaction
is particularly signiﬁcant: black corresponds to the immediate early stage; green,
delayed early stage; blue, late lytic or lysogenic stage. Other symbols are described
in the legend to Figure 1-1. Not all interactions or components are depicted. This
ﬁgure was inspired in part by Figure 6 of ref [130].
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Figure 1-3: Cell fate outcomes at diﬀerent times during growth of a culture.
Aliquots from cultures of E. coli K12 were infected at an average of 2-4 phage per
cell. The proportion of each type of response was determined. The lytic and lysogenic
responses are described in the main text. In the lethal response, the cell dies but does
not produce viable phage particles. Refractory cells neither die nor become lysogens,
and might simply be uninfected; they produce daughter cells which, if infected, can
give rise to any of the responses described here. This image was modiﬁed from
reference [104]
to the lysis-lysogeny decision statistics.
RNaseIII upregulates translation of lambda N and cIII, but represses
translation of cII
RNaseIII is a host-encoded, double-strand-speciﬁc ribonuclease. RNaseIII expression ap-
pears to be controlled by cell growth rate, with higher growth rates giving higher levels of
RNaseIII [178]. RNaseIII regulates the expression of at least three lambda genes: N, cII
and cIII (Figure 1-4, p.24). RNaseIII regulates N translation in three ways [177,178]. First,
RNaseIII can cleave and thereby remove a large stem-loop structure at +76 to +208 of the
N open reading frame. The hairpin is thought to sterically interfere with recognition of the
N mRNA Shine-Dalgarno sequence; higher RNaseIII levels therefore lead to higher levels of
N expression. Second, RNaseIII also upregulates N expression by preventing the formation
of a negative regulatory complex that represses translation of N. Cleavage of the N leader
sequence by RNaseIII can activate N expression ∼200-fold under some conditions. Third,
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Figure 1-4: Host inﬂuences on phage lambda regulators of the lysis-lysogeny
decision. Arrows indicate positive interactions, bars indicate negative interactions.
Brown boxes indicate host factors and yellow circles represent lambda genes and
corresponding gene products. Not all interactions are depicted.
cleavage by RNaseIII upstream of N can reduce the half-life of the N message. Unlike the
ﬁrst two mechanisms, higher RNaseIII would, in this case, result in lower N expression.
However, given that the levels of N are higher in a wild-type cell than in a mutant that
cannot express RNaseIII (rnc−), the net eﬀect of RNaseIII is the upregulation of N.
The levels of N, early during infection, may play a role in determining the outcome
of the lambda lysis-lysogeny decision. For example, infection of cells that constitutively
overexpress N from a plasmid results in clear plaques, a phenotype indicative of a lower
probability of lysogeny [178]. Moreover, stabilization of N by infection of a lon− mutant
also results in clear plaques [58]. However, CII is destabilized in a lon background [58], so
it is unclear whether lytic growth is promoted due to the eﬀect of lon on N, CII, or both.
Nevertheless, the RNaseIII control of N expression therefore provides a possible mechanism
by which an infected cell could sense and respond to variation in growth rate. RNaseIII
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promotes cIII translation, possibly by binding and thereby stabilizing a conformation of
the cIII mRNA that results in more eﬃcient translation [8, 9, 90]. Contrary to its eﬀect on
cIII, RNaseIII represses cII translation by cleaving the double-stranded RNA formed by cII
mRNA and oop RNA, a short transcript antisense to the 3’ end of the cII message [96].
In summary, RNaseIII downregulates translation of cII, but upregulates translation
of lambda N and cIII. What is the net eﬀect of RNaseIII on the fate statistics of lambda
infected cells? Growth of lambda on rnc− cells produces clear plaques; this phenotype can be
suppressed by mutations that increase translation of cIII [7–9]. These observations suggest
that upregulation of cIII by RNaseIII may be the dominant eﬀect. However, the impact of
a quantitative reduction of RNaseIII levels may be distinct from complete abolishment of
RNaseIII activity (as in rnc− cells) [178].
FtsH/HﬂB degrades CII and CIII, but is inhibited by CIII
FtsH/HﬂB is an essential ATP-dependent protease thought to play a key role in the lambda
lysis-lysogeny decision [17, 54, 74, 87, 130, 131]. FtsH is located in the membrane [74]; it
associates with HﬂK and HﬂC, possibly assembling into a FtsH6HﬂKC6 holoenzyme, of
which there are less than 100 per cell [74]. HﬂK and HﬂC appear to act as functional
modulators of FtsH function [5, 80–82].
FtsH is thought to impact the lysis-lysogeny decision by aﬀecting the stability of lambda
CII and CIII ( [81, 87], Figure 1.4). CII carries a ﬂexible C-terminal domain of 16 amino
acids that is necessary and suﬃcient for FtsH-mediated degradation [35,86,87]. In vivo, CII
has a half-life of ∼1-2 minutes [81,87]. Conditions or mutations that increase the stability
of CII typically result in a consequent increase in the frequency of lysogeny. For example,
mutations in ftsH, hflK and hflC which increase the half-life of CII also promote lysogeny
[65, 81]. Given that loss-of-function mutants of hflK and hflC allow a higher frequency
of lysogeny, is it surprising that overexpression of HﬂKC also stabilizes CII and increases
the frequency of lysogeny [81]. Overexpression of FtsH and loss-of-function mutations of
CII have the more expected ﬁnding of promoting lytic growth: in these conditions, lambda
infection results in clear plaque formation [17, 168]. Higher temperature results in higher
FtsH activity and lowered CII half-life [86]; however, higher temperature does not always
increase the frequency of lysogeny [65, 86]. Finally, mutations in hflD, a peripheral host
membrane protein posited to recruit CII to the membrane for FtsH-mediated proteolysis,
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also reduce CII stability and probability of lysogeny in vivo [83].
CIII, a small phage-encoded 54-residues peptide, inhibits FtsH-mediated degradation of
CII by acting as a competitive inhibitor [89]. CIII is itself degraded by FtsH, but with slower
kinetics (half-life of ∼7 min) than CII [66]. CIII inhibits FtsH by binding to FtsH but not
to CII [61]. CIII can be associated with the membrane, either by a direct interaction with
the inner membrane, or by virtue of its association with FtsH [66]. CIII can dimerize [61]
or oligomerize [89], and the formation of higher-order structures may be critical for its
function [89]. Conditions that increase CIII expression increase the frequency of lysogeny,
while those which lower CIII levels favor lytic growth [9,17,42,72,85,91].
The evidence presented above is consistent with a model wherein stability of CII is
critical in regulating the lysis-lysogeny decision. However, deletion or mutation of the
signal which identiﬁed CII for FtsH-mediated degradation increases CII stability but does
not consistently result in higher frequencies of lysogeny [86]. Nevertheless, FtsH-mediated
degradation of CII appears to play an important role in the lysis-lysogeny decision.
How might FtsH sense nutritional conditions and respond by aﬀecting fate outcomes of
lambda infected cells? It has been suggested that at higher levels of nutrition, FtsH-related
proteolytic activity is increased, leading to shorter CII and CIII half-lives [13]. However, to
my knowledge, this hypothesis has never been tested. One mechanism by which the activity
of FtsH may be modulated during growth phase involves the C-terminal self-processing by
FtsH in vivo, which results in the removal of the last 7 C-terminal residues [4]. This
processing is aﬀected by the growth phase of the cells, with increased processing observed
in stationary phase relative to exponential phase. However, both processed and unprocessed
forms of FtsH are able to degrade CII. Nevertheless, CII stability may be quantitatively
aﬀected by the processing of FtsH. It is therefore not known whether C-terminal processing
of FtsH may be responsible for the increased frequencies of lysogeny observed as host cells
are grown to saturation.
Polyadenylated oop RNA downregulates cII expression
As discussed previously (section 1.2.1, p.23), oop RNA can lower translation of the cII
message via a double-stranded association with cII mRNA, and subsequent cleavage of
double-stranded product by RNaseIII. In bacteria, polyadenylated RNA molecules are typ-
ically degraded faster than non-modiﬁed transcripts [75]. Degradation of oop RNA appears
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to be more eﬃcient in slower growing cells due to higher levels of the RNA polyadenylation
enzyme PAP I [75]. So even if RNaseIII levels are higher in LB than minimal medium
(section 1.2.1, p.23), the half-life of the oop message is longer in cells grown in LB (cellular
doubling time = 34 min; oop half-life of ∼1.5 min) than in cells grown in a glycerol minimal
medium (cellular doubling rate = 119 min, oop half-life of ∼0.1 min). This ﬁnding sug-
gests that CII expression may be greater in slower growing cells due to lower expression of
the oop transcript, presumably resulting in higher frequencies of lysogeny. The regulation
of oop degradation by growth conditions is therefore a potential mechanism by which the
environment may tune the frequency of lysogeny.
Why does the frequency of lysogeny vary with growth rate?
The mechanisms by which the lambda regulatory network can sense and respond to variation
in environmental conditions is still not fully understood [37]. In this section, I have described
three possible mechanisms (RNaseIII activity, FtsH activity, oop polyadenylation), which
may couple growth rate to cell fate statistics. Given the extensive interactions between the
bacterial host and lambda infection, there remains the possibility that other mechanisms
are at play too [32,51,87,113,132].
1.2.2 Regulation of the lysis-lysogeny decision by the multi-
plicity of infection
The frequency of lysogeny increases with the multiplicity of infection (MOI), the number
of lambda particles concurrently infecting a given cell ( [52, 85, 92, 104]; Figure 1-5, page
28). Increased frequencies of lysogeny with higher MOI have also been observed for other
temperate phages, such as λ22 [52] or P22 [24, 100]. How lambda senses and responds
to MOI is not completely understood [130]. Which phage-encoded genes are involved in
the multiplicity dependent character of lysis-lysogeny decision? Increasing copy number of
cI [142,143], cII [41] and cIII [41,142,143] were all observed to promote CI synthesis, which
is typically considered to be a marker of lysogeny [9,63,85,143].
Kourilsky identiﬁed diﬀerent determinants of the MOI response depending on the geno-
type of the phage used. When using Q− phage strains, he found that the copy number
of cII (and possibly of cIII), but not of cI, impacts the probability of lysogeny [93]. In
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Figure 1-5: Frequency of lysogeny as a function of the average phage input.
Exponentially growing cells were starved in 10 mM MgSO4 and infected with diﬀerent
phage:cell ratios (here termed “average phage input” or a.p.i.). The diﬀerent symbols
represent diﬀerent experiments where the frequency of lysogeny was calculated using
diﬀerent protocols. Note that the frequency of lysogeny is represented here as the
percentage of all cells (infected or uninfected) which became lysogens. The frequency
of lysogeny as the percentage of infected cells which become lysogens also increases as
a function of a.p.i. (data not shown). This image is reproduced from reference: [91].
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replication-deﬁcient phages (P−), however, cI, cII and cIII all promoted lysogeny. The use
of P− and Q− phage strains complicates the interpretation of Kourilsky’s results for under-
standing the lysis-lysogeny decision with wild-type lambda, which is replication-competent
(P+) and able to activate late lytic functions (Q+). Nevertheless, all the studies presented
in this section, considered together, identify cI, cII and cIII as candidate genes involved in
the MOI response. These results are consistent with other studies suggesting that CII and
CIII can be rate-limiting for lysogenization (e.g. [20,76]).
Several mechanistic models may explain the multiplicity dependent character of lysog-
enization [93]. Perhaps the most parsimonious is the “gene dosage” model, whereby addi-
tional copies of certain lambda pro-lysogeny genes may increase the overall rate of expression
of those genes [29,93]. However, higher MOI also increases lytic genes such as cro or Q. Per-
haps lysogeny is comparatively favored at higher MOI because of the products of lysogenic
genes may require oligomerization for their activity, and exhibit a signiﬁcant concentration
dependence for oligomerization [29]. Consistent with this hypothesis, tetramerization of
CII [35] and oligomerization of CI [38, 135, 137] appear to have functional consequences
on their activity. Nevertheless, further experimentation is needed to directly test whether
lambda responds to the MOI via its eﬀect on the dosage of speciﬁc lambda regulator genes.
1.3 Genetically identical cells, infected by a sin-
gle phage, can produce diﬀerent developmen-
tal outcomes
Across many conditions, genetically identical cells grown in the same environment and each
infected with a single lambda particle select diﬀerent cell fates: some cells lyse while other
cells become lysogens [86, 104, 105]. This variability in cell fate is unlikely to be due to
genetic variation within the phage population or to an artifact of the experimental methods
used to grow infected cells or quantify developmental outcomes ( [104], Chapter 2). Given
this, how do genetically identical cells infected with the same number of phage particles
give rise to distinct cell fates?
In considering this question, cell fate selection during lambda infection has emerged
as a paradigm for how biochemical “noise” might account for diﬀerences in developmental
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outcomes [13, 114, 164, 174]. In particular, Arkin and colleagues used a detailed stochas-
tic chemical kinetics model of lambda infection to analyze if the lysis-lysogeny decision
might be driven by spontaneous diﬀerences in the timing of individual biochemical reac-
tion events [13]. In the “Arkin model”, initially identical newly infected cells are expected
to spontaneously accumulate quantitative diﬀerences in the abundances of key regulatory
molecules, which then propagate through the lysis-lysogeny “decision circuitry” and result
in distinct cell fates (Figure 1-6a, p.31).
The Arkin model is important for at least two reasons. First, the model revitalized study
of how lambda infected cells produce distinct cell fates, recognizing that the existing detailed
descriptions of the individual molecular components of phage lambda are not suﬃcient to
explain such system-level behavior. Second, Arkin and colleagues mapped the process of cell
fate selection onto an explicit model of intracellular physics, which forces a recognition of the
fact that many systems in biology are comprised of components whose cellular abundances
are far below levels for which continuous approximations of chemical kinetics are valid [55],
and for which precision of behavior cannot be expected to emerge via the bulk averaging of
many individual reaction events [152].
The Arkin model also makes a strong claim — cell fate diﬀerences in lambda-infected E.
coli arise due to spontaneous biochemical noise during infection. However, to my knowledge,
no experiments have been carried out to test this hypothesis. Thus in framing my thesis
research, I considered an alternative model for lambda infection suggested by Lieb, Gros and
Kourilsky decades ago [91,94,104]. In the alternative model, variation in the lysis-lysogeny
decision may result from cell-cell variability present prior to infection (Figure 1-6b, p.31).
This PhD thesis describes my eﬀorts to test and explore these models.
1.4 Thesis overview
Chapter 2∗ — Host volume is a predictor of the lambda lysis-lysogeny decision, population
measurements
I ﬁrst explain why I selected cellular volume as a plausible predictor of cell fate. I then
describe how I developed and optimized methods to size-fractionate asynchronous
populations of cells via counterﬂow centrifugal elutriation. Results obtained with
cultures of stationary phase cells show that host volume can be used to predict the
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Figure 1-6: Alternative models for cell fate selection in a population of
genetically identical cells. a, Variation during infection (for example, spontaneous
chemical kinetic noise) leads to qualitative diﬀerences in cell fate. b, Variation in the
physical state of individual cells prior to infection predetermines cell fate.
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fate of lambda infected cells: smaller cells tend to become lysogens, while larger cells
tend to follow lytic growth.
Chapter 3∗ — Host volume is a predictor of the lambda lysis-lysogeny decision, single-cell
microscopy measurements
I present the development of a microscopy platform to study lambda infection in single
cells. Using this platform, I present results that further support the main conclusion
of Chapter 2: the lambda lysis-lysogeny decision is correlated with the volume of
individual, stationary phase cells. My single cell results show that while volume is a
strong predictor of cell fate, it does not fully account for the observed variability in
cell fate selection.
Chapter 4∗ — Identiﬁcation of host-encoded determinants of lambda’s “volume sensor”
I describe eﬀorts to understand whether lambda may be sensitive to a cellular pa-
rameter correlated with volume rather than volume more directly. I ﬁrst show that
sensitivity to host volume is not speciﬁc to infection of stationary phase cells. I then
describe ongoing eﬀorts to determine whether lambda may be sensitive to cell cycle
position rather than volume.
Chapter 5 — Identiﬁcation of phage-encoded determinants of lambda’s “volume sensor”
I describe how characterization of the timing of the lysis-lysogeny decision can help
to identify phage-encoded components underlying lambda’s apparent sensitivity to
host volume. In particular, I discuss the construction of a ﬂuorescent reporter of
CII activity. Preliminary results using this reporter suggest that the lysis-lysogeny
decision has been made before or at the level of CII activity.
Chapter 6 — Detection and enumeration of individual phage particles
I describe ongoing attempts to create a reporter of the multiplicity of infection (MOI),
and how such a reporter would enable the study of the decision in wild-type hosts
grown to exponential phase.
Chapter 7 — Summary
Here, I summarize the results from previous Chapters, highlight opportunities for
future research, and put my work in the larger context of research on cell fate selection.
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∗ Parts of Chapters 2, 3 and 4 are published in: F. St-Pierre and D. Endy. Determination
of cell fate selection during phage lambda infection. Proceedings of the National Academy
of Sciences of the United States of America, 105(52):20705-10, Dec 30 2008.
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Chapter 2
Host volume is a predictor of the
lambda lysis-lysogeny decision,
population measurements
2.1 Host volume is a plausible marker of cell fate
In Chapter 1, I brieﬂy described an alternative model for lambda infection in which cell-cell
variability that exists prior to infection determines individual cell fates (Figure 1-6b). Given
the extent of interactions between host and phage (1; [51]), variability in a large number of
host functions could plausibly impact the lambda lysis-lysogeny decision.
To select a candidate predictor1 of cell fate onto which to focus my initial eﬀorts, I
considered past work showing that the frequency of lysogeny increases with the average
number of infecting phage per cell ( [92]; Chapter 1). To explain this observation, Kourilsky
proposed that lysogeny requires the concentrations of one or more phage-encoded factors
to exceed a critical threshold [93, 95]. The amount of pro-lysogeny factors produced in an
infected cell may be greater when the levels of their corresponding genes are high, either
because many phage are simultaneously infecting the same cell [92], or because the infected
1For the purpose of this thesis, I deﬁne “predictor” as a cellular characteristic, measured prior
to (or immediately after the start of) infection by phage lambda, that correlates with the eventual
fate of the cell (lysis or lysogeny). Examples of such cellular characteristics may be morphological
parameters (volume, surface area, shape), or the abundance, activity or localization of a given
molecular species (e.g. a given protein or mRNA). A predictor implies correlation, not causality.
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cell is small (this work). For cells infected with the same number of phage, I might therefore
predict that, at least early during infection, smaller cells will have an increased concentration
of pro-lysogeny gene products and may tend to become lysogens; larger cells will have a
lower concentration of pro-lysogeny gene products and might favor lytic growth. Particularly
important examples of such pro-lysogeny factors are lambda CII and CIII, whose levels are
known to impact the lysis-lysogeny decision (see section: 1.2, p.20). However, the levels of
other phage-encoded gene products – for example, lambda N – may also play a role (also
discussed in section 1.2, p.20).
According to this “gene dosage” model, host volume may be a plausible marker of
lambda infected cells. Modeling of the lambda right operator region (oR), performed prior
to the start of my experimental work, also suggested that sensitivity to host volume can be
encoded in lambda regulatory circuit (see Chapter 5), further motivating the experimental
validation of volume as a marker of cell fate.
Note that the precise nature of a putative correlation between the volume and fate
of lambda infected cells is considered in Chapter 4. For example, lambda might be sen-
sitive to position within the cell division cycle rather than host volume. Thus, with the
understanding that volume may be a proxy for other cellular parameters, I next consid-
ered experiments to test whether host volume may be used to predict the outcome of the
lysis-lysogeny decision.
2.2 Macroscopic plate methods can be used to quan-
tify cell fate statistics
2.2.1 Preparation of stationary phase Escherichia coli MG1655
Before testing host volume as a candidate marker of the lambda lysis-lysogeny decision, I
evaluated and developed methods to quantify cell fate selection statistics. For my exper-
iments, I used the "wild-type" Escherichia coli K12 strain MG1655 (F− lambda− rph-1)
whose genome has been completely sequenced [22].
Because the multiplicity of infection (MOI) is known to impact cell fate selection (see
above and Chapter 1), I ensured that virtually all cells were infected at the same MOI
(MOI=1) by using a low phage-to-cell ratio (0.005 or otherwise noted). However, wild-type
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Figure 2-1: Growth curves of Escherichia coli MG1655 approaching sta-
tionary phase in tryptone broth at 37℃. I grew ﬁve cultures of Escherichia
coli MG1655 from independent colonies as described in the main text. Aliquots from
each culture were diluted 3-fold into TB for OD600 measurement via a Shimatzu
UV160U spectrophotometer (Shimadzu Scientiﬁc Instruments, Columbia, MD, USA).
The time represents the number of hours following the 500-fold dilution in 0.5L TB
(see main text). I typically harvested cells for size-fractionation and/or infection 16
hours post-dilution. Dilution and time-independent measurement error was deter-
mined by comparing the OD600 readings of 10 separate 3-fold dilutions of stationary
phase cells. The coeﬃcient of variation of those measurements was <1%.
cells grown to early exponential phase, and immediately2 infected with a single phage, are
thought to typically follow the lytic pathway exclusively [92]. Thus, to raise the frequency
of lysogeny to measurable levels, I starved the cells by growing them to stationary phase, a
growth phase reported to produce high fractions of both lytic events and lysogens [92,104].
Speciﬁcally, I ﬁrst grew MG1655 cultures in tryptone broth (TB; [151]) at 37℃ to an OD600
of 0.40, as measured by a UV160U spectrophotometer (Shimadzu Scientiﬁc Instruments,
Columbia, MD, USA). I then diluted the culture 500-fold into 0.5L of TB in a 2.8 L baﬄed
ﬂask, and continued growth with shaking (220rpm) and aeration for 16 hours at 37℃ (see
Figure 2-1 for growth curves).
2Without ﬁrst starving the cells by growing them in media without a carbon source
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2.2.2 Quantiﬁcation of cell fate outcomes
I measured developmental outcomes using λ cI857 bor ::KanR, a lambda strain constructed
by Lynn Thomason in the laboratory of Donald L. Court (NCI-Frederick, Frederick, MD,
USA). This strain has two important characteristics. First, the phage produces only lytic
cells at temperatures above 40℃ due to the temperature sensitive allele (cI857) of the
lambda repressor cI. Second, the phage contains a KanR cassette integrated into the lambda
genome as a partial replacement of the bor locus. This cassette permits selection of lysogens
as kanamycin-resistant colonies. Note that bor is not known to be involved in the lysis-
lysogeny decision. I conﬁrmed that inactivation of bor does not impact lambda decision
by comparing population-average cell fate statistics in MG1655 cells infected with cI857
bor ::KanR or with wild-type lambda (Figure 2-2, page 39).
To measure cell fate outcomes, I followed the procedure sketched in Figure 2-3 (p.40).
I ﬁrst resuspended cells to 1E9 cells/ml in ice cold TB supplemented with 10 mM MgSO4.
I added phage at an average phage-to-cell ratio of 0.005 (λ cI857 bor ::KanR) or 0.05 (λ+).
This phage-to-cell ratio was calculated by titering phage and cells using standard methods
[11]; because of unadsorbed phage, the actual (i.e. eﬀective) phage-to-cell ratio was typically
40-60% lower (data not shown).
I incubated cell-phage mixtures at 4℃ for 30 min to allow for adsorption. I removed
unadsorbed phage by centrifugation. I then diluted cells 10-fold in TB supplemented with
1mM MgSO4 pre-warmed to 30℃. I incubated cells at 30℃ with shaking and aeration
for 45 min, after which I placed cultures on ice; this incubation step is necessary to allow
newly lysogenic cells to develop kanamycin resistance (λ cI857 bor ::KanR) or superinfection
homoimmunity (λ+). I removed any remaining unadsorbed phage by a ﬁnal centrifugation
step.
I independently measured lysis, lysogeny, and total infected cells. I measured the number
of lytic cells by using TB soft agar to disperse cells on TB agar plates containing ∼6E7
plating cells, incubating at 30℃, and counting plaque forming units (PFU). Plating cells
are simply additional cells that are sensitive to lambda infection and allow propagation of
lambda infection, so that individual infected cells can produce clear areas (plaques) on a
lawn a bacterial cells. I made plating cells by growing MG1655 in TB supplemented with
0.2% maltose to exponential phase and resuspending the culture to ∼6E8 cells/ml in TB
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Figure 2-2: Genetically identical cells, each infected with a single phage,
can produce distinct developmental outcomes. a, Four independent infected
cultures produce similar fractions of lytic and lysogenic outcomes, the sum of which
equals an independent measure of total infected cells. b, Population-wide cell fate
statistics are insensitive to the method of lysogeny quantitation. The error bars
represent the standard error of the mean of three infections made with independent
stocks of λ cI857 bor ::KanR. c, A culture of stationary phase cells was infected with
three independent stocks of λ+ and three independent stocks of λ cI857 bor ::KanR.
The percentage lysogeny is the number of lysogens over the total number of infected
cells (here calculated as the sum of lysogens and lytic events). The error bars represent
the standard error of the mean of infections made with three independent stocks of
λ cI857 bor ::KanR or λ+.
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Figure 2-3: Macroscopic plate tests to quantify developmental outcome of
lambda infected cells, sketch of experimental procedure. The major steps of
the experimental protocols are shown above. The duration of the steps is indicated
where appropriate.
supplemented with 10 mM MgSO4.
For experiments using λ cI857 bor ::KanR, I measured the number of lysogenic cells by
spreading cells on TB agar supplemented with 20 μg/ml kanamycin sulfate. When plating
uninfected cells on kanamycin agar, I usually obtained no false positives; in a few cases,
up to 0.001% of plated cells gave false positives (data not shown). For experiments using
λ+, I selected lysogens as cells resistant to homoimmune superinfection. Speciﬁcally, I
spread infected cells on TB agar seeded with ∼1E9 cI26, a lambda mutant that kills any
non-lysogenic lambda-sensitive cells. When plating uninfected cells on cI26-seeded agar,
∼0.01% of cells produced colonies (false positives). For both λ+ and λ cI857 bor ::KanR,
I incubated plates at 30℃ and scored lysogens by counting the number of colony forming
units (CFU).
For cells infected with λ cI857 bor ::KanR, I independently measured the total number
of infected cells by preparing plates as if to count lytic events, with the exception that the
plates were incubated at 42℃. At 42℃, the temperature-sensitive lambda repressor cI857
is inactive, so all infected cells select the lytic pathway and can be counted as PFU.
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I found that stationary phase MG1655 produced 45-50% lysogeny (Figure 2-2a, p.39).
Across four replicate experiments, the sum of independent measurements of lysogens and
lytic centers was equivalent to my independent measurement of the total number of infected
cells. I saw no diﬀerence in the frequency of lysogenization whether I used kanamycin or
resistance to homoimmune superinfection as a method to select lysogens (2-2b). Both λ
cI857 bor ::KanR and λ+ produced identical frequencies of lysogeny (Figure 2-2c, p.39),
suggesting that the cI857 and bor ::KanR alleles do not interfere with the lambda lysis-
lysogeny decision in my experimental conditions. Because selection using kanamycin is
simpler and produces a lower false positive background, I used λ cI857 bor ::KanR for all
subsequent experiments in this Chapter, unless otherwise noted.
2.3 Counterﬂow centrifugal elutriation can produce
fractions of E. coli cells with diﬀerent mean
cell volumes
2.3.1 Size fractionation of cultures of Escherichia coli
To test whether host size can be used to predict the fate of infected cells, I required a
method to obtain fractions of diﬀerent mean cell volume from stationary phase cultures of
Escherichia coli. I present here two methods that were initially considered:
“Baby machine”
One method developed by Helmsletter and Cummings, the “baby machine”, involves the
collection of recently divided cells, which are typically the smallest cells of a culture [19,62].
Brieﬂy, exponentially growing cells are attached to a nitrocellulose membrane, and growth
medium is ﬂowed onto the cells. Newborn cells simply fall in a receptacle. Larger cells (cells
further into the cell division cycle) can be obtained by growing smaller cells in culture media
for a given amount of time. Unfortunately, this method can probably only be used with
exponentially growing cells, because growth media needed to allow cells to divide (to obtain
newborns) and to grow (to obtain larger cells) prevent cells from remaining in stationary
phase.
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Flow cytometry
Forward angle light scatter (FALS) has been used to estimate bacterial cell size [23, 147].
I therefore performed pilot studies using a MoFlo ﬂow cytometer and cell sorter (Dako,
Glostrup, Denmark) at the MIT Flow Cytometry Core Facility. I collected two cell frac-
tions, one for cells with the 10% smallest FALS signal, and one with cells with the 10%
largest FALS signal. However, volume measurements using a Coulter counter (see later this
Chapter) showed identical mean cell volumes for the two fractions. Discrepancy between
published data and the results from my pilot experiment might be due to instrumenta-
tion diﬀerences. I did not consider this method further, and concentrated on counterﬂow
centrifugal elutriation (next).
2.3.2 Development of counterﬂow centrifugal elutriation meth-
ods
Counterﬂow centrifugal elutriation (elutriation) fractionates cell based on diﬀerences in
terminal sedimentation velocity, which is correlated with cell size [49]. Elutriation has
previously been used to isolate fractions of small E. coli cells from asynchronous populations
[49]. Here, I developed protocols to obtain many fractions of E. coli cells across a range of
mean cell volumes (MCV). I used a JE5.0 counterﬂow centrifugal elutriation (elutriation)
system equipped with a single 40 ml chamber pre-cooled to 4℃ (Beckman Coulter, Fullerton,
CA, USA). I controlled cell and medium ﬂow rate via a peristaltic pump loaded with small
pump head cartridges and ﬁtted with L/S14 silicon tubing (Cole-Parmer, Vernon Hills,
IL, USA). I increased fraction quality by using two anti-parallel pump heads and a pulse-
damping chamber to improve continuity of ﬂow in the elutriation chamber; the damping
chamber also trapped small bubbles that otherwise would have disrupted ﬂow within the
chamber or caused rotor vibration. I switched the pulse-damping chamber on-line after
cell loading by means of a three-way valve. Figure 2-4 (p.44) depicts the most important
features of my setup.
Note that I also designed an air purge system to remove air from the JE5.0 elutriation
rotor equipped with a large (40ml) elutriation chamber. The necessary ﬂow rate to remove
air from my system is 200 ml/min (Ref. The JE5.0 Elutriation System, Instruction Manual,
© 2004). Unfortunately, the maximal ﬂow rate of my system is only ∼31 ml/min: at the
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Part Part Number
Elutriation pump∗
1. Masterﬂex L/S variable speed digital economy drive HV-07524-50
2. Masterﬂex L/S 2-channel, 6-roller pump head HV-07519-10
3. Masterﬂex L/S small cartridges HV-07519-85
Air purge pump∗
1. Masterﬂex L/S variable speed digital economy drive HV-07524-50
2. Masterﬂex L/S Easy-Load pump head HV-07518-10
3. Masterﬂex L/S 17 tubing (6.4mm inside diameter),
peroxide-cured
HV-96400-17
Masterﬂex pulse dampener∗ HV-07596-20
Masterﬂex L/S 14 tubing (0.6mm inside diameter),
peroxide-cured∗
HV-96400-14
3-way valves i.e. 3-way stopcocks with Luer connections,
male-lock∗
HV-30600-02
JE5.0 elutriation system with large (40ml) chamber and
pressure gauge∗∗
Contact Beckman
Coulter
∗Cole-Parmer Instrument Company ∗∗Beckman-Coulter
Table 2.1: Elutriation system parts list. All equipment was from Cole-Parmer
Instrument (Vernon Hills, IL, USA, www.coleparmer.com), with the exception of
the JE5.0 elutriation system, which is from Beckman Coulter (Fullerton, CA, USA,
www.beckmancoulter.com). See Figure 2-4 (p.44) for a sketch of my elutriation sys-
tem.
maximal pump drive speed of 100rpm, small cartridges equipped with L/S 14 tubing give an
output of ∼15.6 ml/min per cartridge. I therefore had to use a second drive with the same
maximal speed of 100rpm, but equipped with an Easyload pump head loaded with L/S 17
tubing. This second drive was able to achieve ﬂow rates of up to 280ml/min. A 3-way valve
was used to control whether the “air purge pump drive” or my normal “elutriation pump
drive” was switched on-line. Note that it may be possible to ﬁnd a pump system (pump
drive, pump head and tubing) that could be used both to purge air out of the elutriation
system and to produce the ﬂow rates used in my protocols.
I developed two elutriation protocols, optimized to isolate smaller and larger MG1655
cells, respectively. During an experiment, I carried out each protocol in parallel using two
independent elutriation systems. For both protocols, I ﬁrst ﬁlled the system with an ice-cold
solution of M9 salts, purged any air from each elutriation system and brought the rotors
to 4800 RPM for at least 15 minutes before cell loading. I vortexed cells vigorously for 2
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Figure 2-4: Schematic of counterﬂow centrifugal elutriation system. The
speciﬁc parts used in my system are listed in Table 2.1 (p.43). This setup was inspired
by [170] and the JE5.0 elutriation system instruction manual (©2004). As described
in the main text, I used two identically-conﬁgured elutriation systems in parallel for
most of my experiments.
minutes prior to loading to reduce cell clumping in the elutriation chambers. I then loaded
each elutriation system with 120 ml of cells at a ﬂow rate of 3 ml/min. To collect fractions of
small MG1655 cells, I kept the ﬂow rate at 3 ml/min for 20 min to allow cells to equilibrate
in the chamber. I then increased the ﬂow rate to 4, 5 and then 6 ml/min, collecting 0.5
L at each ﬂow rate. I collected small cells from the 6 ml/min fraction, and discarded all
other fractions. To collect fractions of larger MG1655 cells, after loading the cells into the
elutriator, I slowly increased the ﬂow rate to 7 ml/min. I then increased the ﬂow rate from
7 to 13 ml/min in 1 ml/min steps, collecting 0.5 L at each ﬂow rate. I collected increasing
volume cells from the 9, 10, 11, 12 and 13 ml/min fractions (I only collected 0.1 L at the
13 ml/min ﬂow rate) (Table 2.2).
2.3.3 Elutriation does not grossly aﬀect cell fate selection
statistics
I tested if elutriation may have aﬀected cellular physiology in such a way that it grossly in-
ﬂuenced the lysis/lysogeny decision. To do this, I performed elutriation using the described
methods except that elutriated cells were continuously pumped back into the system. Cells
that underwent elutriation in this way exhibited the same developmental statistics as cells
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Flow rate at which
the fraction was
collected (ml/min)
Fraction vol-
ume (L)
Approximate yield
(% of loaded cells col-
lected in the fraction)
6 0.5 1
9 0.5 5
10 0.5 6
11 0.5 6.5
12 0.5 6.5
13 0.1 1
Table 2.2: Yield of fractions collected by counterﬂow centrifugal elutria-
tion. Fractions produced by elutriation were concentrated ∼100-fold in 1x M9 by
centrifugation. Cells from the asynchronous population used to load the elutriation
system were resuspended in the same medium (1x M9). The OD600 of the result-
ing cell suspensions was measured using an ND-1000 spectrophotometer (NanoDrop,
Wilmington, DE, USA). Assuming 1E9 colony forming units (CFUs) per OD600 per
ml for all fractions independently of mean cell volume, I calculated an estimate of
the number of cells collected in each fraction. The numbers shown above represent
the average of measurements made on elutriated fractions from three independent
stationary phase cell cultures. Note that yields do not sum up to 100% of loaded
cells, because only collected fractions were included in this analysis.
from the same culture that were not loaded into my elutriation systems (Figure 2-5).
I tested if subjecting cells to elutriation, and thus to centrifugal and counterﬂow forces,
can aﬀect their physiology in such a way that it inﬂuenced the lysis-lysogeny decision fol-
lowing infection by phage lamdba. To do this, I performed elutriation for the same duration
(∼6.5 hours) as for the elutriation experiments presented in the next sections of this Chap-
ter. Moreover, to increase the probability of observing an impact of elutriation on the
lysis-lysogeny decision, fractionated cells – that is, cells which left the elutriation system –
were continously reintroduced into the elutriation apparatus. Cells that underwent elutria-
tion in this way exhibited the same developmental statistics as cells from the same culture
that were not loaded into my elutriation systems (Figure 2-5, 46). This result suggests
that the process of elutriation, performed as described earlier, does not cause a measurable
impact on the lambda lysis-lysogeny decision.
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Figure 2-5: Counterﬂow centrifugal elutriation does not result in qualitative
changes in developmental outcome statistics of lambda-infected cells. Elu-
triation was performed as described in Section 2.3.2 (p.42). However, as explained
in the text, I continously reintroduced fractionated cells back into the elutriation
system. To do this, I made two changes to the setup depicted in Figure 2-4 (44).
First, the sample reservoir was the only reservoir used. The outﬂow of the system,
including fractionated cells, was collected into the sample reservoir so that it could
then be pumped back into the system. Second, the pulse dampener was not used
to avoid cells accumulating in its chamber. This setup was used for both elutriation
systems, and the two protocols described earlier (Section 2.3.2, p.42) were followed
in parallel. At the end of the procedure, cells were collected into separate containers
by using a high ﬂow rate (>20 ml/min) to wash out the cells, and manual removal of
the cell pellet which usually forms at the distal end of the elutriation chamber. Cells
loaded in the two elutriation systems, as well as cells from the same population but
which were not loaded in either of the elutriation systems, were infected with phage
lambda and their developmental outcomes quantiﬁed. The error bars represent the
Poisson error of plating.
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2.3.4 Electronic and microscopy measurements of cell size
I measured the volumes of individual cells in each fraction by two methods: light microscopy
and electronic volume. For microscopy measurements, I spread cells on 0.85% NaCl agarose
pads and took pictures using a TE2000-E inverted microscope equipped with a 60x DM
phase contrast objective, 1.5x intermediate magniﬁcation (Nikon USA, Melville, NY, USA)
and an ORCA-AG CCD camera (Hamamatsu Photonics K.K., Japan) controlled by IPLab
v3.9 software (BD Biosciences, Rockville, MD, USA). I manually measured the long axis
of more than 500 cells per fraction. I converted cell length measurements (pixels) to ab-
solute length (microns) using a calibration slide (AppliedPrecision, Issaquah, WA, USA).
I converted measured cell lengths to cell volumes by modeling cells as hemisphere-capped
cylinders: cell volume = 4/3πr3 + (L−2r)πr2, where ’L’ is the cell length and ’r’ is the half
the cell diameter ’r’ was assumed to be identical (0.44 μm) for all cells. I chose this value
of ’r’ by measuring the mean cell diameter of over 500 cells from an asynchronous MG1655
population grown as described above.
To obtain electronic volume measurements, I used an NPE Cell Quanta Hg/488 equipped
with 25 μm ﬂow chamber (NPE Systems, Pembroke Pines, FL, USA)(106). To better
separate cell volume measurements from electronic noise, I stained cells Syto-9 (Invitrogen,
Carlsbad, CA, USA) and triggered on ﬂuorescence rather than volume. For staining, I
ﬁrst diluted cells to ∼1E6 cells/ml in NPE isodiluent (NPE Systems, Pembroke Pines,
FL, USA) and incubated with 2 μM Syto-9 for 30 min at 4℃ in the dark. I calibrated
my electronic volume measurements by spiking cell suspensions with 1.51 μm yellow-green
ﬂuorescent polystyrene beads (Excitation: 425 nm, Emission: 480 nm; Catalog No. FS04F,
Bangs Labs, Fishers, IN, USA). Cells and beads were excited with a 488 nm laser and their
emission monitored using a 525/30 nm emission ﬁlter. Electronic volume (gain setting=10)
and ﬂuorescence were recorded for more than 10,000 cells and 5,000 beads per fraction.
Electronic and microscopy measurements of fraction mean cell volumes gave similar values
(Figure 2-6, p.48), and conﬁrmed that elutriation can be used to produce fractions with
diﬀerent mean cell volumes (Figure 2-7,p.49).
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Figure 2-6: Comparison of mean cell volume obtained by electronic and
microscopic measurements. Mean cell volume for the 21 fractions included in 2-11
(p.54) was obtained by microscopic and electronic measurements as described earlier.
The equation of the linear trendline is y = 0.0069x + 0.4668, and the correlation
coeﬃcient (r2) is 0.823.
Volume measurements of septating cells
Many cells in fractions of larger cells appear to be septating (see Figure 2-7, p.49). I assumed
that both “halves” of septating cells can freely exchange molecules during phage infection, so
that size measurements should include the entire cell. This assumption is further supported
by time-lapse movies of individual cells infected by a phage strain constitutively expressing
GFP (see Chapter 3, p.61). In these movies, GFP is seen to ﬁll up the entire septating cell,
rather than only half of the cell (data not shown). However, I cannot exclude the possibility
that certain macromolecules, such as phage DNA, cannot cross partially formed septa.
The volume of a septating cell was calculated identically to the volume of a non-septating
cell with the same length. My microscopy measurements therefore overestimate the volume
of septating cells. However, this overestimation may be slight, as electronic and microscopy
measurement gave similar results (Figure 2-6, p.48).
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Microscopy:
  MCV: 0.82 µm3    
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Smaller cells
Microscopy:
  MCV: 1.29 µm3 
  CoV:  22.8 %       
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Microscopy:
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Figure 2-7: Genetically identical cells can be separated into many fractions
with diﬀerent mean cell volumes. Asynchronous cultures of stationary phase E.
coli MG1655 were sorted using counterﬂow centrifugal elutriation (Methods). The
distribution of cell volumes obtained by microscopy (n > 500) and electronic (n >
10,000) measurements are shown for representative small (a) and large (c) fractions,
as well as for the starting asynchronous population (e). Representative phase contrast
pictures (b, d, f) are shown to the right of the corresponding volume distributions.
The black bar at the bottom right corner of each image represents a length of 5 μm.
MCV = mean cell volume; CoV = coeﬃcient of variation.
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2.4 Host volume is a marker of cell fate
Having established methods to segregate cells based on size, measure cell volumes and
quantify cell fate outcomes, I next set out to test the hypothesis that host volume can
be used to predict the fate of lambda infected cells. I grew three independent cultures of
MG1655 as described earlier and collected cell fractions with mean cell volumes (MCV)
between 0.82 and 1.33 μm3, giving a MCV ratio of ∼1.6 between the largest and smallest
fractions (Figure 2-11, p.54; Figure 2-8, p.51; Figure 2-9, p.52; Figure 2-10, p.53).
I infected each cell fraction and quantiﬁed developmental outcome. Across the ∼1.6-fold
range of MCV fractions, I observed a ∼3-fold diﬀerence in the percentage lysogeny (Figure
I also tested whether my results might be due to diﬀerences in the number of dead or
non-growing cells across the diﬀerent fractions used. To do this, I followed via microscopy
over 250 cells from both a low MCV fraction (0.83 μm3 MCV; 71.5% lysogeny) and a high
MCV fraction (1.26 μm3 MCV; 24.9% lysogeny). In both cases more than 98% of observed
cells grew and divided.
Since cells were incubated for 45 min at 30℃ in liquid medium between phage adsorption
and plating (above), cell division or lysis could have occurred during this period, potentially
skewing the developmental outcome statistics. However, I found no increase in plaque counts
during this incubation period for both high and low MCV fractions, suggesting that lysis
did not occur prior to plating (Figure 2-14, p.57). Similarly, I observed no increase in colony
counts during this 45-minute incubation step (Figure 2-13, p.56). By following > 200 cells
by time-lapse microscopy, I conﬁrmed that it takes more than 45 minutes to observe the
ﬁrst cell division (data not shown). This lag in cell division may result from my use of
stationary phase cells.
Finally, my experiment used unpuriﬁed stocks of phage lambda. However, I conﬁrmed
that a correlation between volume and fate of infected cells is also observed with puriﬁed
phage stocks (See section 3.2, p.64).
My initial results therefore strongly suggested that host volume immediately prior to
infection can be used to predict the fate of lambda infected cells: larger cells tend to lyse,
while smaller cells tend to become lytic.
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Figure 2-8: Volume histograms of elutriated fractions of Figure 2-11 (p.54),
squares series
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Figure 2-9: Volume histograms of elutriated fractions of Figure 2-11 (p.54),
triangle series
52
0.6 0.8 1 1.2 1.4 1.6 1.8 2
5
10
15
20
25
30
35
40
45
N
um
be
r o
f c
el
ls 
(as
 %
 of
 to
tal
)
0.6 0.8 1 1.2 1.4 1.6 1.8 2
5
10
15
20
25
30
35
40
45
N
um
be
r o
f c
el
ls 
(as
 %
 of
 to
tal
)
0.6 0.8 1 1.2 1.4 1.6 1.8 2
5
10
15
20
25
30
35
40
45
N
um
be
r o
f c
el
ls 
(as
 %
 of
 to
tal
)
0.6 0.8 1 1.2 1.4 1.6 1.8 2
5
10
15
20
25
30
35
40
45
N
um
be
r o
f c
el
ls 
(as
 %
 of
 to
tal
)
0.6 0.8 1 1.2 1.4 1.6 1.8 2
5
10
15
20
25
30
35
40
45
N
um
be
r o
f c
el
ls 
(as
 %
 of
 to
tal
)
0.6 0.8 1 1.2 1.4 1.6 1.8 2
5
10
15
20
25
30
35
40
45
N
um
be
r o
f c
el
ls 
(as
 %
 of
 to
tal
)
0.6 0.8 1 1.2 1.4 1.6 1.8 2
5
10
15
20
25
30
35
40
45
N
um
be
r o
f c
el
ls 
(as
 %
 of
 to
tal
) Asynchronous
population
Fraction
6 ml/min
Fraction
9 ml/min
Fraction
10 ml/min
Fraction
11 ml/min
Fraction
12 ml/min
Fraction
13 ml/min
Cell volume (µm3 )
Cell volume (µm3 )
Cell volume (µm3 )
Cell volume (µm3 ) Cell volume (µm3 )
Cell volume (µm3 )
Cell volume (µm3 )
Microscopy:
MCV: 1.08 µm3
CoV: 22.8 % 
Electronic volume:
MCV: 1.11 µm3
CoV: 21.3 % 
Microscopy:
MCV: 1.14 µm3
CoV: 22.9 % 
Electronic volume:
MCV: 1.09 µm3
CoV: 20.6 % 
Microscopy:
MCV: 1.29 µm3
CoV: 22.8 % 
Electronic volume:
MCV: 1.25 µm3
CoV: 19.9 % 
Microscopy:
MCV: 1.13 µm3
CoV: 35.0 % 
Electronic volume:
MCV: 1.14 µm3
CoV: 21.9 % 
Microscopy:
MCV: 1.18 µm3
CoV: 29.6 % 
Electronic volume:
MCV: 1.15 µm3
CoV: 22.2 % 
Microscopy:
MCV: 1.21 µm3
CoV: 22.8 % 
Electronic volume:
MCV: 1.19 µm3
CoV: 21.3 % 
Microscopy:
MCV: 0.82 µm3
CoV: 12.9 % 
Electronic volume:
MCV: 0.81 µm3
CoV: 17.5 % 
Figure 2-10: Volume histograms of elutriated fractions of Figure 2-11 (p.54),
circles series
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Figure 2-11: Physical variation can be used to predict the lysis-lysogeny
decision (population measurements of stationary phase MG1655 cells). In-
dependent measurements of the fraction of lytic events and lysogeny as a function of
the mean cell volume for diﬀerent cell fractions. Developmental outcome is expressed
as a percentage of an independent measure of the total number of infected cells for
each fraction. Circles, triangles, and squares depict fractions collected from inde-
pendent experiments. The three starting asynchronous (unfractionated) cultures are
also shown (arrows). Error bars depict the Poisson standard error of the mean from
plating. Dashed lines depict linear regression lines for percentage lysis and lysogeny,
and the sum of lytic events and lysogens.
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Figure 2-12: Comparison of developmental statistics of fractions of smaller
and larger infected cells. From the fractions illustrated in Figure 2.9, I further
analyzed three small MCV fractions and three large MCV fractions. Each group was
composed of fractions obtained from independent cultures. The small MCV fractions
gave an average of 66.8% lysogeny, over 3 times the percentage lysogeny observed in
the large MCV fractions, 22.0% (p=0.002, 2-tail paired t-test). The same fractions
gave a corresponding change in frequency of lytic events: I observed 27.3% lytic events
in the small MCV fractions compared to 80.3% in the large MCV fractions (p=0.003,
2-tail paired t-test). The error bars represent the standard error of the mean of three
independent fractions.
2.5 Critical volume analysis
No cell fraction obtained via the elutriator and plating method produced 100% lysogens
or 100% lytic events (Figure 2.9). However, each elutriated fraction was comprised of cells
spanning a range of volumes (Figure 2-7,49; Figure 2.8). Thus, I was unsure if the occurrence
of both lysis and lysogeny in each fraction might be due to stochastic processes intrinsic
to infection within individual cells, or to remaining pre-existing extrinsic diﬀerences in cell
volume (or another variable) that were beyond the segregation capabilities of my elutriation
method.
Given the observed sensitivity to pre-existing diﬀerences in cell volume, I was partic-
ularly curious if volume at the time of infection might entirely account for the eventual
fate of infected cells. To quickly consider this possibility I used a single parameter abstract
“all-or-none” model to posit that any cells smaller than a “critical volume” might produce
a lysogen, while any larger cell would undergo lysis (Figure 2.13a). I then used this critical
volume model to analyze data obtained by elutriation and plating. Speciﬁcally, I compared
the observed frequency of lysogeny to the frequency of lysogeny that would be predicted
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Figure 2-13: The total number of cells does not increase during the 45-
minute incubation step between adsorption and plating. I grew and size-
fractionated three independent cultures of bacterial cells. For each culture, I selected
the fraction with the smallest mean cell volume (MCV) and the fraction with the
largest MCV. To replicate experimental conditions of my usual infection protocol
(except for the addition of phages), I resuspended cells in TB supplemented with
10 mM MgSO4, incubated them at 4℃ for 30 minutes and diluted them in TB pre-
warmed to 30℃. Cells were then plated on TB agar either immediately following
dilution, or after a 45-minute incubation at 30℃ with aeration in a roller drum.
Plates were incubated at 30℃ for ∼18 hours and scored for colony forming units
(CFUs). For each experiment and each fraction, the number of CFUs obtained after
the 45 min incubation period was normalized to the value obtained when cells were
plated before incubation. The error bars represent the standard error of the mean
of those three independent experiments. The values given for the mean cell volume
represent the mean of the MCV of three fractions.
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Figure 2-14: The total number of infected cells does not change during
the 45-minute incubation step between adsorption and plating. I grew and
size-fractionated a culture of bacterial cells. The fraction with the largest mean cell
volume (MCV) and the fraction with the smallest MCV were infected with λ cI857
bor ::KanR. After the usual adsorption step (30 min, 4℃), cells from each fraction were
split into three treatment groups. Some cells were submitted to a 5-min pulse at 37℃
and plated either immediately (Condition A), or after the usual 45-min incubation
at 30℃ (Condition B). The 37℃ pulse was performed to ensure phage DNA ejection
prior to plating [?], thus avoiding potential eﬀects of plating conditions on DNA
entry probability. Cell treated exactly as described in Supplementary Methods (i.e.
45 min incubation at 30 C but no 5-min pulse at 37℃) were also plated (Condition C).
Infected cells were scored as plaque forming units (PFUs) on plates incubated at 42℃.
The error bars represent the standard error of the mean of three replicate experiments
performed using cells from the same fraction. For each replicate experiment, the
number of PFUs obtained in Conditions A and B was normalized to the number of
PFUs obtained from Condition C.
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Figure 2-15: “Critical volume” analysis. a, Cartoon representation of my con-
cept of “critical volume”. In this simple hypothesis, all cells greater than this critical
volume become lytic, while all cells smaller than the critical volume become lysogens.
b, Correlation between the observed frequency of lysogeny obtained by experimenta-
tion, and the percentage lysogeny predicted by my critical volume model. Each data
point represents one of the 21 fractions analyzed in Figure 2.9. c, Fraction-speciﬁc
“critical volumes”. The horizontal bar: the center dash represents the mean, 10% of
the population fall within the inner dashes, and 90% within the outer dashes. Most
critical volume points fall within the inner dashes.
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using the all-or-none model, ﬁtting for the best critical volume across all cell fractions. The
best-ﬁt critical volume model (1.04 m3) is a good predictor (r2=0.93, p < 1E-04) of observed
cell fate (Figure 2.13b).
For comparison, I also calculated a critical volume for each fraction independently by
determining the volume at which the percentage of cells of lesser volume is equal to the
observed probability of lysogeny in that fraction. For example, the observed percentage
lysogeny for the indicated fraction (Figure 2.13c, arrow) is 17.7%, and the critical volume
for this fraction is determined as the volume for which 17.7% of the cells are of lesser volume
(1.02 μm3). From this complementary analysis I observed that the critical volumes across
all MCV fractions were concentrated within a range of cell volumes that are much narrower
than the volume distribution of the starting asynchronous population.
To be clear, my mathematical analysis does not conclusively establish a critical volume
all-or-none model, nor reveal anything about molecular mechanisms that would underlie
such behavior. However, it suggests that my cell fraction data is not grossly or obviously
inconsistent with an all-or-none deterministic model for lambda infection (Figure 1.6b) in
which cells smaller than a putative critical volume (∼1 μm3) will become lysogens. My
analysis also highlighted the need to develop experimental methods for directly exploring
the correlation between host volume and ensuing cell fate at the single cell level, the topic
of the next Chapter.
2.6 Chapter summary
Re-interpretation of experiments by Lieb, Kourilsky and others [52, 85, 92, 104] motivated
the selection of cellular volume as a possible predictor of cell fate. I developed and optimized
methods of counterﬂow centrifugal elutriation to size-fractionate asynchronous populations
of E. coli cells. Results obtained with cultures of stationary phase cells show that physical
variation present prior to infection can control the fate of lambda infected cells: smaller
cells tend to become lysogens, while larger cells tend to follow lytic growth.
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2.7 Chapter acknowledgments
Donald Court (Gene Regulation and Chromosome Biology Laboratory, Center for Cancer
Research, National Cancer Institute-Frederick, Frederick, MD) suggested cell volume as a
potential marker of cell fate
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Chapter 3
Host volume is a predictor of the
lambda lysis-lysogeny decision,
single-cell microscopy
measurements
In Chapter 2, I demonstrated that host volume can be used to predict the fate of lambda
infected cells. In this Chapter, I present the development and utilization of a microscopy
platform to study lambda infection at the single cell level. I wished to develop this platform
for two primary reasons. First, I wanted to conﬁrm the results of Chapter 2 using a diﬀerent
method to observe cells of diﬀerent volume and determine cell fate selection statistics.
Second, to quantify, at the single cell level, the extent to which host volume is correlated
with the fate of lambda infected cells.
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3.1 Design and construction of λ Aam19 b::GFP
cI857
3.1.1 Designing a phage strain for single-cell microscopy
Detecting all infected cells using a phage-encoded GFP cassette
I ﬁrst set out to replicate the experimental conditions described in the previous Chapter,
namely infection of MG1655 grown to stationary phase in tryptone broth (TB). As in
Chapter 2, I controlled the multiplicity of infection (MOI) by using a low average number
(0.03) of phage per cell. Lytic events can be simply detected using brightﬁeld microscopy
due to cell lysis. However, I needed a method to distinguish lysogens from uninfected
cells. To detect all infected cells, including lysogens, I integrated into the lambda genome
a cassette that results in the constitutive expression of the green ﬂuorescent protein. The
cassette was inserted in the “b” region of phage lambda [30], a region not thought to play
a role in the lambda lysis-lysogeny decision. I considered alternative methods of detection
such as those further described in Chapter 6. However, I chose the phage-encoded GFP
cassette method because it is relatively simple and less likely to signiﬁcantly perturb lambda
regulatory network.
Using an amber mutation in gene A to prevent re-infection of lambda
infected cells
I wished to avoid complications arising from re-infection of infected cells by the progeny
of neighboring cells which underwent lysis. To this end, I introduced an amber mutation
in gene A (Aam19 allele) into λ b::GFP . The A gene encodes an essential phage DNA
packaging enzyme [46] not thought to be involved in the cell fate selection process. Strains
which do not suppress the amber mutations, such as those used in my experiments, can still
lyse because the phage-encoded holin-endolysin system for host cell lysis (genes R and S)
remains intact. Importantly, lysed cells only release empty (uninfectious) lambda particles,
thus preventing re-infection.
To allow a simpler detection of Aam19 mutants, I engineered a cI857 mutation onto
λ b::GFP prior to engineering the Aam19 mutation (see construction section below). The
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cI857 allele results in fully active CI repressor at temperatures of < ∼32℃, but non-
functional CI at temperatures > ∼40℃ [163].
At 40℃-42℃, λ Aam19 cI857 mutants produce clear plaques when plated on an amber-
suppressor strain (e.g. C600) but cannot be propagated on non-suppressor strains(e.g.
MG1655). They are thus easily distinguished from the A+ cI857 parental strain which
forms clear plaques when plated on either strain [131]. The details of the construction of λ
Aam19 b::GFP cI857 are presented below:
3.1.2 Construction of λ Aam19 b::GFP cI857
Recombineering of a GFP cassette onto lambda genome
I ﬁrst selected a GFP cassette from pSB3K3-I20115 [1], a plasmid constructed by Heather
Thompson and Matt Gethers in my laboratory. When using the primers described below
for PCR ampliﬁcation, the resulting GFP cassette contained the following critical elements:
1. BBa_E0040 [1], a BioBrickTM [84] version of the bright GFP variant gfpmut3b, with
a strong ribosome binding site (RBS) from phage T7 gene 2.0. BBa_E0040 was
driven by a strong, LacI-repressible promoter BBa_R0011 [1]. In the presence of
IPTG or in a ΔlacI strain, this cassette produces GFP constitutively, as desired for
my application.
2. The kanamycin resistance marker from the plasmid, to allow selection for phage
carrying the GFP cassette.
3. Two terminators, BBa_B0015 and the E. coli his operon terminator, separating gfp
from the kanamycin marker.
I ﬁrst PCR-ampliﬁed the above mentioned GFP cassette using primers containing 20 bp
of homology to the GFP cassette and 48-50 bp of homology to lambda b region:
• Forward primer:
5’-aggcagcaaaatcatcagaaacgaacgcatcatcaagtgccggtcgtgca-
aactttatccgcctccatcc-3’
• Reverse primer:
5’-ccgtatccttcacccaggctgtgccgttccacttctgatattcccctcc-
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cgtgaagaaggtgttgctga-3’
I used ethanol puriﬁcation to desalt and concentrate my PCR product, and performed
membrane dialysis for further desalting. I performed recombineering on an infectious
lambda wild-type particle using the recombineering strain DY380 and published meth-
ods [167]. To select for recombinants, I infected MG1655 cells grown to stationary phase
with the recombineering lysate and plated on LB supplemented with 20 μg/ml kanamycin.
Putative λ b::GFP lysogens were conﬁrmed by PCR and ﬂuorescence microscopy. Stocks
of λ b::GFP were derived from these lysogens using standard methods [63].
The resulting phage contained the 2,662 nt GFP cassette integrated into the b region [30]
of the phage genome, replacing the wild-type lambda sequence between lambda coordinates
20430-22278 and producing a phage whose genome is only slightly longer (813 nt or 1.7%)
than wild-type λ. The added sequence is well within the range giving eﬃcient DNA packag-
ing [47]. I reconﬁrmed the presence of the cassette on the phage by ﬂuorescence microscopy
and by DNA sequencing.
Recombineering cI857 and Aam19 onto λ b::GFP
I next engineered the Aam19 (C→T at lambda coordinate 1917) and cI857 (C→T at lambda
coordinate 37742) mutations onto λ b::GFP using published methods of recombineering
using single stranded oligonucleotides [131, 167]. I identiﬁed recombinants by plaque mor-
phology and conﬁrmed the presence of the mutations by DNA sequencing and ﬂuorescence
microscopy.
3.2 Host volume is a predictor of the fate of single
lambda infected cells
The newly constructed phage strain, λ Aam19 b::GFP cI857, produces bright ﬂuorescence
upon infection, allowing easy detection of infected cells. I performed single cell experiments
using the same bacterial strain and culture conditions as previously used in the elutriation
and plating experiments (wild-type E. coli grown to stationary phase in TB). I infected
cells at low multiplicity (average phage:cell ratio of ∼0.03) and recorded time-lapse movies
via automated ﬂuorescence and brightﬁeld microscopy. For all single cell experiments men-
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tioned in this thesis, the phage:cell ratio was determined directly by counting the number
of infected (i.e. GFP expressing) cells and the total number of cells. The phage:cell ratio
was approximately what was expected given the number of phage added, and the number
of unadsorbed phage which I removed by centrifugation prior to imaging (data not shown).
I determined the cell size of infected cells by direct manual measurement of cell length
of the ﬁrst frame of each time-lapse movie. Cell size could also have been measured using
the movie frame where GFP ﬂuorescence is ﬁrst detected. However, such a method would
result in measurement bias if either:
1. ﬂuorescence is detected at diﬀerent times in cells fated to become lysogens compared
to cells fated to produce lytic events, or:
2. the lysogeny and the lytic pathway diﬀerentially impact cell growth prior to appear-
ance of GFP. If true, diﬀerences in volumes between cells fated to become lytics and
cells fated to become lysogens may be caused by the chosen pathway, rather than
being a true predictor of cell fate.
Measurements of cell lengths were converted into measurements of cell volume as described
in Section 2.3.4 (p.47).
I established cell fates as described in Figure 3-1 (p.66). Brieﬂy, I scored an infection as a
lytic event when a GFP-expressing cell or both of its daughters lysed. I did not observe any
instance of lysis in cells that did not previously express GFP. An infected cell was presumed
to be a lysogen when it survived the infection, producing two daughters which also divided.
Stable lysogeny requires integration of lambda DNA into the host chromosome [130]. While
my system did not allow me to determine whether integration took place, the overall cell
fate selection statistics from my microscopy experiments were equivalent to those obtained
via my elutriation and plating method (see later).
In a minority of cases, I observed an infected cell giving rise to two daughters, one
which lysed and one which survived and divided; such events were scored as ’mixed fate’.
In some ’mixed fate’ events, ﬂuorescence appeared to decrease as the surviving cell grew
and divided. Perhaps such loss of ﬂuorescence is due to changes in growth conditions as the
agarose pad became crowded and cells presumably left exponential phase. Increased number
of cells may also reduce accessibility of IPTG, which is required to induce expression from
the GFP cassette (see 3.1.2, p.63). An alternative possibility is that the surviving cell and
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Cell fates
Classification % of total (counts)Infected 
cell
Daughters of infected cell
Daughter A Daughter B
Lyses n/a n/a Lytic event 55.6 (175)
Divides
Lyses Lyses Lytic event 0.3 (1)
Lyses Divides Mixed fate 5.1 (16)
Divides Divides Lysogeny 39.0 (123)
100 (315)
Figure 3-1: Cell fate selection statistics via time-lapse microscopy, station-
ary phase MG1655 cells. Cultures of MG1655 were grown to stationary phase
in tryptone broth and infected at low API (phage:cell) with λ Aam19 b::GFP cI857.
I obtained approximately 1 infected (GFP-expressing) cell for every 30 cells. The
developmental outcome of infected cells and, if applicable, their daughter cells, was
monitored by time-lapse microscopy. The “classiﬁcation” column outlines my map-
ping of developmental outcomes (lysis or division) of infected cells to overall cell fate
outcomes. In some cases, the fate of an infected cell or one or both of its daughters
could not be determined either because (1) the cell moved out of the ﬁeld of view or
became obscured by neighboring cells, (2) the cell did not divide or lyse before the
end of the time-lapse movie. Such ambiguous cases were not included in this table or
in any analyses.
its progeny somehow remained uninfected. A direct reporter of lysogeny, such as a reporter
of integration, would help distinguish between these hypotheses.
The percentage lysogeny from my microscopy experiments (41.1%) closely matched
that obtained via my elutriation and plating method (44.2±4.0% S.E.M). The majority of
infected cells which divided produced lysogens (123 of 140). Interestingly, a minority of
infected, dividing cells (16 of 140) produced oﬀspring that obtained distinct cell fates - one
daughter cell lysed while the other formed an lysogen or continued to grow and divide. I
also observed one case in which a cell appeared to have divided, giving rise to daughters
that both gave a lytic response.
I estimated the initial size of each infected cell by measuring cell length immediately
following infection. I combined the initial cell size and cell fate data in order to determine
to what extent the size of individual cells predetermines cell fates. Consistent with my
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Figure 3-2: Physical variation can be used to predict the lysis-lysogeny deci-
sion (single cell measurements of stationary phase MG1655 cells). Probabil-
ity of lysogeny as a function of the length of individual MG1655 grown to stationary
phase. The numbers in parentheses represent the number of lysogens over the total
number of infected cells within each volume bin. The dashed lines correspond to the
average percentage lysogeny.
elutriation-based results, I observed that in individual stationary phase cells the probability
of lysogeny is greatest in the smallest cells (p=0.61) and decreases with increasing cell size
(p=0.12) (Figure 3-2, p.67). While volume was a predictor of cell fate, I did not ﬁnd a
“critical volume” below which all cells became lysogens, and above which all cells produced
lytic events.
Phage stocks used in my microscopy and elutriation experiments were unpuriﬁed; my
results might therefore be an artifact of some component present in my phage stocks. To test
this possibility, I puriﬁed a stock of λ Aam19 b::GFP cI857 by diﬀerential sedimentation
and isopycnic centrifugation in CsCl gradients, using standard protocols [11]. Using this
puriﬁed phage stock, I infected one culture of MG1655 grown to stationary phase in TB,
and found that volume remained a predictor of cell fate. For example, the average volume
of lysogens (count=22 cells) was 0.84 μm3, while the average volume of lytics (count=89
cells) was 1.16 μm3. For comparison, in the experiments shown in Figure 3-2 (p.67), the
average volume of lysogens was 0.92 μm3 (count=123 cells) while the average volume of
lytics was 1.11 μm3 (count=176 cells). For all data points presented above, the standard
67
error of the mean is <0.03 μm3. This control experiment suggests that the presence of a
correlation between the volume and fate of infected cells is not due to a component present
in my phage stocks. However, puriﬁcation of phage stocks might aﬀect the strength of the
correlation; additional experiments would be needed to determine whether this may be the
case.
3.3 Chapter summary
I constructed a specialized phage strain to observe lambda development at the single cell
level. This strain produces GFP during infection, thereby identifying infected cells. More-
over, it is unable to produce infectious virion progeny, avoiding complications from rein-
fection of the initially infected cells. Results obtained with cultures of stationary phase
cells conﬁrm the main result of Chapter 2: following infection, smaller cells tend to become
lysogens, while larger cells tend to follow lytic growth. Cell volume has thus been shown to
be a marker of cell fate using two diﬀerent methods of observing cells of diﬀerent volumes
and quantifying cell fate statistics (Chapter 2 and this Chapter). Volume does not appear
to be a perfect predictor of cell fate. Other variation, arising before or during infection,
must therefore play a role in regulating the lambda lysis-lysogeny decision.
3.4 Chapter acknowledgments
Felix Moser (Endy lab) introduced the cI857 marker into λ b::GFP by recombineering with
single-stranded oligos (Section 3.1.2, p.64).
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Chapter 4
Identiﬁcation of host-encoded
determinants of lambda’s “volume
sensor”
In Chapters 2 and 3, I presented experimental support to the hypothesis that the volume of
stationary phase cells can be used to predict their fates following lambda infection: larger
cells tend follow the lytic pathway, while smaller cells tend to become lysogens. How might
the lambda regulatory network sense host volume (or a correlated cell parameter)? The the
lambda lysis-lysogeny decision circuit includes both phage- and host-encoded components
[51, 63, 130]. I now describe ongoing eﬀorts to identify host (this Chapter) and phage
(Chapter 5) determinants of lambda’s apparent volume sensitivity. More speciﬁcally, in
this Chapter, I ﬁrst demonstrate that host volume can be a marker of cell fate for both
stationary and exponentially growing cells. Lambda is thus unlikely to “sense” volume via
a host factor present exclusively during stationary phase. I then consider whether lambda
might be responsive to cell cycle position rather than host volume, and describe how these
two host parameters may be decoupled.
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4.1 Is lambda’s sensitivity to host volume speciﬁc
to stationary phase?
Stationary phase cultures are known to be particularly heterogeneous. For example, dilution
of late stationary phase cultures into fresh medium can produce a subpopulation of cells
which start dividing, and another subpopulation with cells which do not [149]. Heterogeneity
in stationary phase is also observed when cells remain in the same medium. For example,
Makinoshima and colleagues were able to fractionate stationary phase cultures into more
than 10 subpopulations based on their buoyant densities and expression of stationary phase
promoters [116].
Lambda may be responsive to heterogeneity within a population of stationary phase
cells given its strong sensitivity to the physiological condition of the host cell (see Section
1.2, p.20). For example, Pearl et al. recently investigated whether persister bacterial cells
are protected from phage infection and induction [133]. Persisters are cells that can survive
a temporary antibiotic exposure; unlike antibiotic resistant cells, their progeny are sensitive
to antibiotics. Type I persistent bacteria, which can arise during stationary phase [16] to
form ∼1% of the population [79], were found to be protected from prophage induction.
However, persisters were not protected from infection. The authors did not investigate
whether the persistence state impacts the lysis-lysogeny decision, and whether there is a
correlation between the size of a cell and its ability to persist. Nevertheless, the results of
Pearl and colleagues suggest that lambda can be sensitive to phenotypic variability arising
during stationary phase.
Given that cells become smaller as they approach and advance within stationary phase
[3], smaller cells within a culture may tend to be those which have progressed further
within stationary phase and may be phenotypically diﬀerent from larger cells. Lambda
may sense and respond to such variability by producing diﬀerent outcome statistics that
are correlated with such cell-cell physical variation. This “starvation stress” model leads to
a strong, testable claim - lambda sensitivity to host volume is speciﬁc to stationary phase.
Using two approaches, I collected evidence inconsistent with the “stationary stress model”:
• I show direct evidence that host volume can be a predictor of the fate of exponentially
growing cells (section 4.1.1, p.71)
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• I describe the development of a single-cell reporter of stationary phase stress. I found
no correlation between cell size and the signal from this reporter (section 4.1.2, p.75)
4.1.1 Variation in the volume of exponentially growing cells
is correlated with lambda developmental outcome
Raising the frequency of lysogenization of exponentially growing cells
To directly test the starvation stress model, I set out to consider whether host volume is a
marker of cell fate not only in conditions of starvation, but also in conditions where cells
are growing exponentially. Unfortunately, cells in early exponential growth in rich media
typically only adopt the lytic pathway when infected at a MOI of 1.
To raise the frequency of lysogeny to observable levels, I considered three approaches.
First, because lambda developmental outcome statistics are sensitive to nutritional condi-
tions [92,95,104], I tried to raise the frequency of lysogeny by using a poor medium: I grew
MG1655 cells to low density (OD600∼0.07, Shimadzu UV160U) in M9 medium [151] sup-
plemented with 0.5% acetate as the sole carbon source. In these conditions, MG1655 grows
with the very slow doubling rate of 4.5-5 hrs at 30℃. I determined the frequency of lysogeny
as described previously (see Section 2.2.2 on p.38), except that the recovery was performed
in M9 acetate for 1 hour. From this single pilot experiment, I obtained a frequency of
lysogeny of 3.5%. I also measured cell fate statistics by single cell microscopy at low MOI
(∼0.03) with λ Aam19 b::GFP cI857. I removed free phage and performed time-lapse mi-
croscopy as described in Chapter 3, except that I used 2% LMP agarose supplemented
in M9 acetate (rather than TB). All ∼50 cells observed lysed, suggesting a frequency of
lysogeny of < 2%. Given the low number of cells observed in this experiment, this result is
not grossly inconsistent with the frequency of lysogeny obtained using the plating method
(3.5%).
A frequency of lysogeny of ∼3.5% (and possibly lower) was determined too low to do
microscopy experiments. As explained in previous Chapters, I wanted to keep the frequency
of cells infected at MOI ≥ 2 small compared compared to the frequency of lysogeny. For
example, and assuming a Poisson distribution of phage onto cells [36], an infection at a
phage:cell ratio of ∼1:143 would result in ∼0.35% of infected cells being infected at MOI
≥ 2, which is small (10-fold lower) than the overall frequency of lysogeny. However, this
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would result in only one lysogen every 4086 cells (infected or not), making it very diﬃcult
to obtain suﬃcient data by microscopy to generate statistically signiﬁcant results.
I also considered increasing the frequency of lysogeny by infecting cells at a higher
multiplicity of infection (MOI). However, given that cell fate statistics are sensitive to MOI,
this strategy requires a reporter of MOI so that only cells infected by the same number of
phage can be compared. Because of the potential importance of a system to count phage
particles, and because of the large number of techniques tested or considered, ongoing eﬀorts
to develop a reporter of MOI are discussed separately (Chapter 6).
Because of the diﬃculty in developing conditions or technology to obtain a high fraction
of lysogeny in wild-type strains, I next considered E. coli mutants giving the high frequency
of lysogeny (hfl) phenotype. Certain mutants, such as MA150 (hflA150) [72], resulted in
abnormal morphology upon infection with lambda (data not shown); other mutants resulted
in signiﬁcant decreases in cell growth rate (e.g. hflB and hflD mutants). hflK ::kanR,
hflC ::kanR and hlfX ::kanR mutants from the Keio collection [15] grew at rates similar to
the parental wild-type strains and did not produce aberrant morphology during lambda
infection (e.g. Figure 4-1, p.73). HlfK and HﬂC are membrane proteins that regulate the
activity of FtsH/HlfB, the main protease degrading lambda CII (Chapter 1). Deletion of
these loci is therefore expected to stabilize CII, but not to change the dynamics of lambda
gene expression during infection. Because the role of HlfX is not known, I was hesitant to
select hflX ::kanR as host strain. The remaining two strains from the Keio collection were
equally suitable; I chose strain JW4132 (Coli Genetic Stock Center # 10975, genotype: F−
lambda− rph-1 Δ(araD-araB)567 lacZ ::rrnB-3 Δ(rhaD-rhaB)568 hflK ::kanR) for further
experimentation.
Preexisting variation in the volume of exponentially growing cells corre-
lates with cell fate outcomes
I diluted overnight cultures of JW4132 in M9GlyM + 10 μg/ml kanamycin (to prevent
contamination) and grew them at 30℃ with vigorous shaking to OD600 ∼ 0.07 (UV160U
spectrophotometer, see above). M9GlyM is M9 [151] supplemented with 0.4% glycerol,
0.2% maltose, 2 mM MgSO4 and 0.1 mM CaCl2. I diluted the culture 1000-fold in fresh
M9GlyM supplemented with 1 mM IPTG (to induce GFP expression following infection
with λ Aam19 b::GFP cI857) and grew the culture back to OD600 ∼ 0.07.
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Figure 4-1: Filmstrips of phage infection of single hflK− cells. Images
from time-lapse movies of exponentially growing JW4132 (hﬂK−) cells infected at
a phage:cell ratio of ∼1:30 with a lambda strain carrying a ﬂuorescent reporter ex-
pression cassette. Numbers indicate the number of minutes at which the images were
taken after the start of each movie. Top row: two neighboring cells are infected, each
presumably at a multiplicity of one, and both cells turn green over time. The upper-
right infected cell is larger and near the end of its cell division cycle, as indicated by
the presence of a membrane invagination (developing septum) at mid-cell. This cell
lyses between t=132 and t=177 min. The lower-left infected cell, which is presum-
ably the product of a recent cell division event and is relatively small, continues to
progress through a typical cell division cycle. The infected cell was presumably lyso-
genized by lambda as it survives the infection, producing viable progeny which also
divide between t=461 and t=520 min. Bottom row: an infected cell produces daugh-
ter cells with apparently distinct fates: the rightmost daughter lyses between t=527
and t=559 min, while the leftmost daughter divides around t=372 min, producing
progeny which themselves divide around t=714 min.
I concentrated cells 10-fold in TM (10 mM Tris-Cl, pH 7.5, 10 mM MgSO4) and infected
cells with λ Aam19 b::GFP cI857 at a phage:cell ratio of ∼1:30. After 30 min at 4℃ for
adsorption of phage onto cells, I removed unadsorbed phage by centrifugation and spread
cells on M9GlyM + 1 mM IPTG + 2% LMP agarose pads. I incubated the cells in a
microscope heating chamber set to 30℃, taking phase contrast and GFP ﬂuorescence images
(75 ms) every ∼ 15 minutes for at least 11 hours at 60-100x magniﬁcation.
Most infected cells lysed (382 of 449), with the majority of the remaining cells producing
lysogens (54 of 67). Figure 4-1 (p.73; top ﬁlmstrip) presents an example ﬁlmstrip showing
two infected cells: one cell produces a lytic response while the other cell survives the infection
as a presumed lysogen. As with the stationary phase conditions (Chapter 3), I again
observed a small number of infected, dividing cells whose oﬀspring obtained distinct cell
fates (7 of 82; and see Figure 4-1, p.73, bottom ﬁlmstrip). Complete cell fate selection
statistics are provided (Figure 4-2, p.74).
As in Chapter 3, I estimated the initial size of each infected cell by measuring cell
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Cell fates
Classification % of total (counts)Infected 
cell
Daughters of infected cell
Daughter A Daughter B
Lyses n/a n/a Lytic event 85.1 (382)
Divides
Lyses Lyses Lytic event 1.3 (6)
Lyses Divides Mixed fate 1.6 (7)
Divides Divides Lysogeny 12.0 (54)
100 (449)
Figure 4-2: Cell fate selection statistics via time-lapse microscopy (single
cell measurements of exponentially growing hflK− cells). Cultures of JW4132
were grown to stationary phase in tryptone broth and infected at low API (phage:cell,
∼1:30) with λ Aam19 b::GFP cI857. The developmental outcome of infected (GFP-
expressing) cells and, if applicable, their daughter cells, was monitored by time-lapse
microscopy. The “classiﬁcation” column outlines my mapping of developmental out-
comes (lysis or division) of infected cells to overall cell fate outcomes. In some cases,
the fate of an infected cell or one or both of its daughters could not be determined
either because (1) the cell moved out of the ﬁeld of view or became obscured by
neighboring cells, (2) the cell did not divide or lyse before the end of the time-lapse
movie. Such ambiguous cases were not included in this table or in any analyses.
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Figure 4-3: Physical variation can be used to predict the lysis-lysogeny
decision (single cell measurements of exponentially growing hflK− cells).
Probability of lysogeny as a function of the length of individual JW4132 (hﬂK−)
grown to exponential phase. The numbers in parentheses represent the number of
lysogens over the total number of infected cells within each volume bin (excluding
“mixed fate” cells). The dashed line corresponds to the average percentage lysogeny.
length immediately following infection. I combined the initial cell size and cell fate data
in order to determine to what extent the size of individual cells predetermines cell fates.
The probability of lysogeny is greatest in the smallest cells (p=0.25) and decreases with
increasing size (p=0.06) (Figure 4-3, p.75). While volume was strongly correlated with cell
fate, once again I did not ﬁnd a “critical volume” below which all cells became lysogens,
and above which all cells produced lytic events.
4.1.2 No correlation is observed between cell size and ﬂuo-
rescence from a reporter of stationary phase stress
The experiments described in the ﬁrst section of this Chapter were started at approximately
the same time as those discussed in Chapter 3. At that time, I did not know whether I
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would be able to develop a platform to directly test whether host variation in the volume of
exponentially growing cells impacts the lambda lysis-lysogeny decision (Section 4.1.1, p.71).
I therefore decided to ﬁnd a second method to investigate whether the apparent sensitivity
to host volume was speciﬁc to stationary phase. In particular, I tried to ﬁnd a correlation
between cell size and a marker of stationary phase, as described next.
Selection and construction of a reporter of stationary phase
Stationary phase is often accompanied and deﬁned by large-scale changes in gene expression
[127]. In narrowing the ﬁeld for potential physiological variables that may impact lambda
development, I considered that the stationary stress response is highly dependent on the
alternative RNA polymerase sigma factor σs [53, 64, 127, 156]. Moreover, σs amount and
activity is promoted by the “alarmone” ppGpp [127]. ppGpp is reported to impact the
lambda pR promoter, thereby modulating the frequency of lysogeny [136, 158]. σs activity
may therefore be a plausible marker of lambda developmental outcome.
I decided to test whether σs activity, as a prototypical marker of stationary phase stress,
might be correlated with cell volume. I used the BioBrickTM device BBa_ J45995 encoding
GFP under the control of the σs-controlled promoter pOsmY [115, 116]. To minimize the
impact of the reporter on host physiology, BBa_ J45995 was ported from a high-copy copy
plasmid (pSB1AT3, pMT1 origin of replication) to a low-copy plasmid (pSB4K5 [155]). As a
control, I used BBa_ I7100, where GFP is driven by the constitutive promoter BBa_R0040.
BBa_I7100 was also ported to pSB4K5. I transformed both plasmids — pSB4K5-J459951
and pSB4K5-I7100 — into MG1655, the same strain used in the experiments described in
Chapters 2 and 3. BBa_J45995, BBa_I7100, pSB1AT3 and pSB4K5 where all obtained
from the Registry of Standard Biological Parts [1].
pSB4K5-J45995 is a reporter of stationary phase
I grew three independent cultures of MG1655 carrying pSB4K5-J45995 in TB to stationary
phase as described in Chapter 2. At diﬀerent points during growth, I spread cells on M9
agarose (2%) pads and imaged at least 300 cells per culture using phase contrast and ﬂuores-
1Following the example of Shetty et al. [155], I represented BioBricks parts cloned within a
BioBrick plasmids by writing the BioBricks vector name, followed by a dash, and the BioBricks part
number, without the use of italics.
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Figure 4-4: Plasmid pSB4K5-J45995 is a reporter of stationary phase.
MG1655/pSB4K5-J45995 was grown in tryptone broth (TB) and aliquots removed
at various time during growth to stationary phase. GFP signal of at least 300 cells
per time point was measured by ﬂuorescence microscopy. Fluorescence is low during
exponential phase (ﬁrst 2-3 points), but increase rapidly as cells approach stationary
phase.
cence (50 ms exposure) microscopy. Cell size (as area on the still pictures) and ﬂuorescence
were extracted by custom Matlab (Mathworks, Natick, USA) scripts. Fluorescence per
μm2 increases with OD600, as expected for a reporter of stationary phase (Figure 4-4). On
the other hand, pSB4K5-I7100 was brightly ﬂuorescent in both exponential and stationary
phase (data not shown).
The reporter of stationary phase stress does not signiﬁcantly impact growth
kinetics or cell fate decision statistics
I grew three independent cultures of (1) MG1655 carrying pSB4K5-J45995 and (2) MG1655
carrying pSB4K5-I7100 in TB to stationary phase, as described in Chapter 2. Aliquots
from each culture were diluted 3-fold into TB for OD600 measurement via a Shimatzu
UV160U spectrophotometer (Shimadzu Scientiﬁc Instruments, Columbia, MD, USA). The
sampling time represents the number of hours following the 500-fold dilution in 0.5L TB
(see Chapter 2). All cultures reached a plateau in OD600 at ∼16 hours after the start
of the culture (Figure 4-5, p.78, as was obtained with plasmid-free MG1655 (Chapter 2).
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Figure 4-5: Growth curves of 3 independent cultures of MG1655/pSB4K5-
J45995 and MG1655/pSB4K5-I7100. Both strains reach a plateau in OD600 at
t ∼16 hours (dotted line), as observed with MG1655 without plasmid (Chapter 2,
Figure 2-1, p.37)
pSB4K5-J45995 also did not aﬀect cell fate decision statistics: infection of stationary phase
MG1655 cells carrying pSB4K5-J45995 gave 50.8±1.0% (n=3, S.E.M.) lysogeny, compared
with 48.9±2.6% (n=3, S.E.M.) for plasmid-free MG1655.
No correlation is observed between cell size and ﬂuorescence from my
reporter of stationary phase stress
Three independent cultures of MG1655/pSB4K5-J45995 and MG1655/pSB4K5-I7100 were
grown to stationary phase, imaged and analyzed as described above. I plotted the ﬂuorescent
per area (μm2) as a function of cell size for MG1655/pSB4K5-J45995 (Figure 4-6a, p.79)
and MG1655/pSB4K5-I7100 (Figure 4-6b, p.79).
For each strain, I divided cells into 6 bins of cell size. I then normalized the val-
ues obtained with the stationary phase reporter (J45995) with those obtained using the
constitutive reporter (I7100). This normalization was necessary to remove variations in ﬂu-
orescence between cells of diﬀerent size that were not speciﬁc to variation in the expression
of the pOsmY promoter.
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Figure 4-6: Fluorescence per area as a function of cell size for stationary
phase cultures of (a) MG1655/pSB4K5-J45995 and (b) MG1655/pSB4K5-
I7100. Cell size is given as the area (in μm2) covered by each cell on my 2D im-
ages. Each dot represent a single cell (n>1000 for each plot), with each color repre-
sent cells from independent cultures (n>300 per culture). Exposure time was 50 ms
(MG1655/pSB4K5-J45995), or 10 ms (MG1655/pSB4K5-I7100).
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Figure 4-7: Cell size is not correlated with signal from the stationary phase
reporter (pSB4K5-J45995). MG1655/pSB4K5-J45995 cells divided into bins, and
their ﬂuorescence per area normalized as described in the main text. Error bars
represent the standard error of the mean.
My results are depicted in Figure 4-7 (p.80), and show no correlation between cell size
and ﬂuorescence from my stationary phase reporter. It is possible that such a correlation
exists, but is either too small to detect or is masked by other sources of variation, such
as cell-cell diﬀerences in plasmid copy number or gene expression capacity. Moreover, my
reporter used GFP with a wild-type terminus, resulting in a very stable protein. The use of
GFP variants with shorter half-lives may have more easily captured more transient changes
in gene expression [101, 169]. Finally, I might not have used the best promoter to report
on cell-cell diﬀerences during stationary phase that impact lambda developmental outcome.
However, given success in developing tools and conditions to study lambda infection in
exponential phase directly (see section 4.1.1, page 71), this line of investigation was not
pursued further.
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4.2 Is lambda sensitive to pre-existing variation in
cell cycle position?
4.2.1 Consideration of cell cycle position as a determinant of
the lambda lysis-lysogeny decision
The results described above show that sensitivity to host volume (or a correlated variable)
can also be observed when cells are grown to exponential phase. With the caveat that these
experiments were done using an hfl mutant rather the wild type, sensitivity to host volume
(or a correlated variable) are likely to be a more general feature of the lambda regulatory
circuit rather than a property speciﬁc to stationary phase.
What aspects of host physiology, correlated with volume, might impact lambda devel-
opment? In Chapter 2, I brieﬂy described a “gene dosage” model wherein variation in host
volume results in variation in the concentration of phage-encoded genes during infections
at constant MOI. In an alternative model, considered here, the lambda lysis-lysogeny de-
cision may be sensitive to the cell cycle position of its host cells, a parameter that is well
correlated with cell volume [19]. In particular, cell cycle position may specify the amount,
localization or activity of host-encoded regulators of the lambda regulatory circuit. For
example, the localization of FtsH in Bacillus subtilis appears to vary throughout the cell
cycle, accumulating at the septum during cell division [173].
Another possible coupling between the E. coli cell cycle and lambda development was
posited by Kourilsky and Gros more than 30 years ago [94]. In their model, cells in which
replication is not proceeding actively are more readily lysogenized. Because the ability of
cells to replicate lambda DNA may be related to their ability to replicate their own genome,
the position of the host cell with respect to its replication cycle may aﬀect the lambda lysis-
lysogeny decision. For example, cells which tend to be lysogenized may be those which have
ﬁnished a DNA replication cycle and have not yet started a new round of replication. A
possible molecular mechanism which could underlie this model might include the two main
regulators of chromosome replication initiation in E. coli, DnaA and SeqA, which are also
regulators of lambda’s pR promoter [56,75]. Activity of pR plays an important role in the
regulation of lambda DNA replication [56,75] and the lysis-lysogeny decision [130].
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4.2.2 Selection of a bacterial strain to decouple cell cycle
position from cell volume
I next set out to test whether lambda may be sensitive to cell cycle position, regardless of
the speciﬁc mechanism that may underlie such a behavior. An obstacle to testing the “cell
cycle” model of lambda infection is the high degree of correlation between cell volume and
cell cycle position in wild-type Escherichia coli cells [19]. To decouple cell volume and cell
position, I considered bacterial mutants for which cell division is controlled by temperature
or by the addition of an exogenous inducer such as IPTG or arabinose. While inhibition of
DNA replication results in inhibition of septation [73], inhibition of cell division typically
does not aﬀect progression through the cell cycle. Continued ability of ﬁlamenting cells to
progress through the cell cycle is evidenced by their ability to replicate DNA and segregate
bacterial chromosomes (e.g. [6, 21,145]).
I transduced ftsA12 leu::Tn10 [33] – a temperature-sensitive allele of the cell division
gene ftsA [33,39,107] linked to a leu::Tn10 marker – from W3110 ftsA12 leu::Tn10 into the
hflK ::kanR strain JW4132 described in the previous section. The resulting strain, FSP-
B207, was shown to elongate at high temperatures (e.g. > 40℃) but to be relatively close
to wild-type lengths at 30℃ (Figure 4-8, p.83).
Using FSP-B207, I can use temperature to decouple cell size from cell cycle position.
The cell cycle model predicts that the frequency of lysogeny should be largely independent of
cell size. On the other hand, the gene dosage model predicts that the frequency of lysogeny
will decrease as cells elongate. Experiments are underway to test those predictions.
4.3 Chapter summary
I obtained evidence that lambda’s apparent sensitivity to host volume is not speciﬁc to
stationary phase. First, using an E. coli mutant strain producing a high frequency of
lysogeny (hflK−), I found that host volume can be a predictor of the fate of cells grown to
exponential phase. Second, I found no correlation between the size of a cell and the signal
from a plasmid-based reporter of stationary phase. Apparent sensitivity to host volume may
thus be a general property of the lambda decision circuit. As with stationary phase cells,
the volume of exponentially growing cells is not a perfect predictor of cell fate. Experiments
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Figure 4-8: Temperature control of septation using JW4132 ftsA12. FSP-
B207 (JW4132 ftsA12) was grown in LB to late log, diluted 10-fold in fresh LB and
incubated at 30℃ (a) or 40℃ (b) for one hour. Cells were then placed on 2% LMP
agarose pads supplemented with TB and imaged with a 60X phase contrast objective.
are underway to determine whether lambda may be directly sensitive to cell cycle position
rather than volume.
4.4 Chapter acknowledgments
• Mingjie Li (Endy lab) collected much of the data for the experiments with the reporter
of stationary phase (Section 4.1.2, p.75) and constructed JW4132 ftsA12 (Section
4.2.2, p.82).
• Felix Moser (Endy lab) ported (1) the GFP reporter of stationary phase (BBa_J45995)
and (2) the cassette expressing GFP constitutively (BBa_I7100) into the low-copy
plasmid pSB4K5 (Section 4.1.2, p.76).
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Chapter 5
Identiﬁcation of phage-encoded
determinants of lambda’s “volume
sensor”
The lambda regulatory network consists of both host-encoded regulators (e.g. FtsH, RNaseIII)
and phage-encoded factors (e.g. CII, CIII). In the previous Chapter, I presented eﬀorts to
uncover what aspect of host physiology, volume or a correlated parameter, impact the
lambda lysis-lysogeny decision. In particular, I found that this “volume sensor” is unlikely
to rely on stationary phase factors, given that host volume is a predictor of cell fate for
both stationary and exponential phase cells. In this Chapter, I describe eﬀorts to identify
phage-encoded determinants of the volume sensor.
5.1 Timing of the lambda lysis-lysogeny decision
To narrow the list of candidate lambda factors critical for lambda sensitivity to host volume,
I ﬁrst considered the use of known lambda mutant strains. Using either the elutriation or
microscopy platforms, I could directly test whether certain genes are critical for the volume
eﬀect. Unfortunately, most of lambda regulators are thought to be critical for lambda’s
ability to lysogenize (e.g., CI, CII), to lyse (e.g., Q, Cro) or both (e.g., N). The use of
most loss-of-function alleles would therefore be expected to reduce the frequency of lysis or
lysogeny to undetectable levels, to signiﬁcantly aﬀect the dynamics of the lambda decision
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circuit, or both.
I detail here a diﬀerent strategy to identify plausible phage factors which participate in
sensing volume (or a correlated variable). In this method, I aim to ﬁnd when the lambda
lysogeny decision is set. Variation in host volume must impact phage-encoded factors acting
upstream of the decision point. As an initial test, I decided to consider whether the decision
is set at the level of CII activity. While the precise timing of the lambda lysis-lysogeny
decision is not known [130,138], CII is often thought as the master regulator of the decision
(see Chapter 1). According to this model, events downstream of CII are involved in the
implementation of the lysis/lysogeny decision, rather than the making of the decision itself.
For example, the lambda repressor (CI) or the lytic antitermination factor Q, would simply
execute the decision made at the level of CII activity.
However, it is not known whether events downstream of CII may play a part in de-
termining cell fate. Indeed, some researchers have questioned the role of CII as the sole
master regulator of the lysis-lysogeny decision [37]. In another example, my advisor Drew
Endy made a computational model of lambda right operator region (oR) which suggests
that asymmetry of cooperativity of CI and Cro at the oR may sense variations in host
volume, resulting in diﬀerent transcription rates of promoters pR and pRM (D.Endy, un-
published). In his model, events largely downstream of CII, such as activation of pRM and
repression of pR by CI, play a role in the decision. Knowing whether and to what extent
the lysis-lysogeny decision is set at the level of CII would allow us to reﬁne my list of plau-
sible phage-encoded factors responsible for the decision and, plausibly, lambda’s apparent
sensitivity to host volume.
5.2 Construction of a CII activity reporter
To construct a reporter of CII activity, I cloned the lambda pRE promoter upstream of
BBa_ Z0301 [1], an E. coli codon-optimized version of Venus YFP. pRE is a CII-activated
promoter which exhibits little transcription in the absence of CII [48]. I chose Venus
YFP due to its brightness and fast (∼15 min) maturation rate, and because of the low
amount of autoﬂuorescence in the yellow part of the spectrum [123]. Moreover, YFP, unlike
GFP, allows the use of CFP (cyan ﬂuorescent protein) in the same system with mini-
mal spectral overlap [153]. Venus was cloned with a strong RBS from phage T7 gene 5
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(5’-aatcaataggagaaatcaat-3’) upstream of the ATG site, with no BioBrick scar, into the
BioBrick vector pSB1AK3. pRE (lambda coordinates 5’-38635 and 38336-3’, [88] and venus
then were cloned into BioBrick vectors using standard BioBrick cloning techniques [1,155].
In choosing suitable BioBrick vectors to clone my pRE-venus construct, I considered
the following criteria. To start, I wanted to minimize copy number to avoid perturbing
the lambda regulatory network via titration of too many CII molecules. Yet, I wanted
the signal to be strong enough for detection. I initially tried pSB4C5, a low-copy (∼5-12
copies/cell, [14,108,151]), chloramphenicol-resistant BioBrick vector with pSC101 origin of
replication [155]. However, very little ﬂuorescence was detected when JW4132/pSB4C5-
pRE-Z0301 was grown to exponential phase in M9GlyM (Chapter 4) and infected at low
multiplicity. I obtained similar results when using pSB4A5 [155], which is identical to
pSB4C5 except for the resistance marker (ampR rather than camR), or pSB3C5 [155] which
has the higher-copy p15A origin of replication (∼15-30 copies/cell, [14,108,151]). I obtained
signiﬁcantly stronger signal using pSB4A3, another low-copy vector with ampicillin resis-
tance and pSC101 origin of replication. Additionally, BBa_I739204 a kanamycin-resistant,
pACYC177-derived BioBrick vector with p15A origin gave us particularly strong signal. I
do not know why pSB4A3 and BBa_ I739204 gave us stronger signal than pSB4A5, pSB4C5
and pSB3C5.
I next transformed BBa_I739204-pRE-Venus and pSB4A3-pRE-Venus into JW4132,
the hflK ::kanR strain described in the previous Chapter. However, because BBa_I739204
is resistant to kanamycin, I ﬁrst removed the FRT-ﬂanked kanR marker from JW4132 using
the ﬂippase from plasmid pCP20 [34], resulting in a partial deletion of the hflK locus. The
resulting strain, FSP-B208, was transformed with each of the two plasmids using published
methods [151].
5.3 Construction of λ Aam19 b::RFP cI857
My reporter of CII activity and λ Aam19 b::GFP cI857 employ ﬂuorescent proteins whose
spectra overlap (YFP and GFP, respectively), motivating the construction of a diﬀerent
lambda strain for detection of infected cells. I decided to use a cassette expressing a red ﬂu-
orescent protein (RFP) because RFP spectra shows minimal overlap with the YFP spectra,
and many RFP variants have maturation times signiﬁcantly faster than the latent period
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of phage lambda in M9GlyM [153].
I ﬁrst tested a version of the GFP cassette identical to that described in Chapter 3, with
the exception that the RFP variant mCherry replaces GFP. I performed recombineering on
phage lambda as described before, using the same primers as those described in Chapter
3, resulting in λ b::mCherry. Unfortunately, the RFP signal from λ b::mCherry was weak
when monitoring infection by time-lapse microscopy, even when using exposure times of 0.5-
1 second and 2x2 binning (data not shown). To obtain stronger signal, I used a diﬀerent RFP
cassette, BBa_E13521. When using the primers described below for PCR ampliﬁcation,
the resulting RFP cassette contained the following critical elements:
• BBa_E1010 encoding the red ﬂuorescent protein mRFP1, with the strong ribosome
binding site BBa_B0034. BBa_E1010 is driven by a strong, TetR-repressible pro-
moter BBa_R0040. In the absence of TetR, BBa_R0040 is constitutive, as desired for
my application. Two terminators, BBa_B0010 and BBa_B0012 are downstream of
mRFP1, to stop transcription from BBa_R0040 past the boundaries of the cassette.
• The ampicillin resistance marker from the plasmid harboring the cassette (pSB1A2),
to allow selection for phage carrying the RFP cassette.
I ﬁrst PCR-ampliﬁed the above-mentioned RFP cassette using primers containing 20-22 bp
of homology to the RFP cassette and 49-50 bp of homology to lambda b region. The se-
quences homologous to the lambda genome are the same as those described in Chapter
3.
• Forward primer (72 bp):
5’-Aggcagcaaaatcatcagaaacgaacgcatcatcaagtgccggtcgtgca
ggatcttcacctagatcctttt
• Reverse primer (69 bp):
5’-Ccgtatccttcacccaggctgtgccgttccacttctgatattcccctcc
gagtcagtgagcgaggaagc
I used ethanol puriﬁcation to desalt and concentrate my PCR product, and performed
membrane dialysis for further desalting. I performed recombineering on an infectious
lambda cI857 particle using the recombineering strain DY380 and published methods [167].
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To select for recombinants, I infected MG1655 cells grown to stationary phase with the re-
combineering lysate and plated on LB supplemented with 20 μg/ml carbenicillin. Putative
λ b::RFP cI857 lysogens were conﬁrmed by PCR and ﬂuorescence microscopy. Stocks of λ
b::RFP cI857 were derived from these lysogens using standard methods [63].
The resulting phage contained my 2,247 nt GFP cassette into the b region [30] of the
phage genome, replacing sequence between lambda coordinates 20430-22278 and producing
a phage only slightly longer (398 nt or ∼0.8%) than wild-type λ. The added sequence
is well within the range giving eﬃcient DNA packaging [47]. I reconﬁrmed the presence
of the cassette on the phage by ﬂuorescence microscopy and by sequencing. The mRFP1
cassette showed signiﬁcantly stronger ﬂuorescence than the mCherry cassette, albeit less
than the GFP cassette. Maturation of mRFP1 (and mCherry) also appeared ∼3 times
slower than the maturation of GFPmut3, the GFP variant used in my GFP cassette. I
crossed λ Aam19 mutation with λ b::RFP cI857 using standard procedures [63], resulting
in λ Aam19 b::RFP cI857, and conﬁrmed the presence of the amber mutation by plating
on suppressor and non-suppressor strains, and by ﬂuorescence microscopy.
5.4 CII is an almost perfect predictor of cell fate
I grew FSP-B208 harboring the low-copy CII reporter pSB4A3-pRE-venus in M9GlyM
as described in the previous Chapter. For pilot experiments, I infected cells at an API
(phage:cell ratio) of ∼1.5, removed free phage by centrifugation, spread cells on M9GlyM
agarose pads and recorded phase contrast and ﬂuorescence (YFP, RFP) images every
∼15minutes (see Figure 5-1, p.90, for example ﬁlmstrips).
I followed 63 infected (RFP-expressing) cells, 24 that adopted lytic growth and 39 that
became lysogens. YFP signal was ﬁrst detected ∼30 min, and peaked ∼75 min after the
start of infection. All 39 cells which became lysogens expressed signiﬁcant YFP signal. 23 of
the 24 cells which became lytic expressed no or little YFP signal. One cell that became lytic
expressed more YFP ﬂuorescence than some cells that became lysogenic. CII activity was
thus a marker of cell fate for 62 of the 63 cells analyzed in this pilot experiment, suggesting
CII is an almost (98%) perfect predictor of cell fate. Preliminary results with the medium-
copy BBa_I739204-pRE-venus vector were qualitatively similar (data not shown). These
results are qualitatively consistent with past work suggesting that CII is a critical regulator
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Figure 5-1: Filmstrips of infection of single hflK− cells harboring a reporter
of CII activity. Images from time-lapse movies of exponentially growing FSP-
B208 (ΔhﬂK ) harboring the plasmid-based, CII activity reporter pSB4A3-pRE-venus.
Cells were grown to exponential phase in M9GlyM and resuspended in TM as pre-
viously described. I infected cells at an API (phage:cell ratio) of ∼1.5, removed free
phage by centrifugation, spread cells on M9GlyM agarose pads and recorded phase
contrast and ﬂuorescence (YFP, RFP) images every ∼15 minutes. Numbers indicate
the number of minutes at which the images were taken after the start of each movie.
The left column pictures are overlays of phase contrast and red ﬂuorescence images.
The top cell and the bottom right cell show red ﬂuorescence, indicative of infection
with λ Aam19 b::RFP cI857 (note that the red ﬂuorescence is very faint for the top
cell). The bottom left cell is not infected. The right column pictures are overlays
of phase contrast and yellow ﬂuorescence (depicted green for visualization purposes).
The top cell does not produce visible ﬂuorescence and lyses between t=184 and t=214
min. The bottom right cell produces signiﬁcant ﬂuorescent signal and survives the
infection, presumably as a lysogen.
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of the lysis-lysogeny decision (Chapter 1).
The experiments presented above merit repetition, ideally at low MOI for comparison
with results presented in Chapter 4. Nevertheless, my preliminary ﬁndings suggest that
events largely downstream of CII — such as activation of pRM and repression of pR by CI
— play a minor role in deciding between lysis and lysogeny. However, such events are likely
to be important in implementing the lysis-lysogeny decision. If my preliminary results hold
up to further experimentation, next steps should involve exploring events upstream of CII
activity.
5.5 Chapter summary
I obtained preliminary results suggesting that CII activity is a near-perfect predictor of the
lambda lysis-lysogeny decision. Lambda’s “volume sensor” is therefore more likely to involve
factors acting upstream of (or at the level of) CII, rather than factors acting downstream
of CII.
5.6 Chapter acknowledgments
• Arun Devabhaktuni (Endy lab) tested the ﬂuorescent reporters of CII activity (Sec-
tion 5.4, p.89) and constructed strain λ b::RFP cI857 (Section 5.3, p.87).
• Mingjie Li (Endy lab) introduced the Aam19 mutation into λ b::RFP cI857 (Section
5.3, p.87).
• Felix Moser (Endy lab) constructed the ﬂuorescent reporters of CII activity (Section
5.4, p.89).
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Chapter 6
Detection and enumeration of
individual phage particles
In Chapter 4 (section 4.1.1, p.71), I described how I used an hflK− mutant to raise the
frequency of lysogeny to levels observable by single-cell analysis of lambda infection. Because
I am interested in studying the lambda regulatory network in wild-type conditions, I also
set out to raise the frequency of lysogeny by infecting wild-type cells at a higher multiplicity
of infection (see Chapter 1). Such conditions require the design of a reporter of multiplicity
of infection (MOI), so that only cells infected with the same number of phage are compared.
To develop a reporter of MOI, I followed two approaches in parallel. In the ﬁrst (section
6.1, this page), I explored methods to determine the MOI by counting the number of phage
capsids adsorbed onto a given cell. In the second method (section 6.2, page 97), I tested
technology to enumerate single phage DNA particles inside host cells.
6.1 Quantiﬁcation of the MOI by labeling phage
capsid
I set out to develop a system to quantify the MOI by labeling phage capsids adsorbed
onto cells. The MOI could then be determined by counting the number of ﬂuorescent foci
detected on a given cell surface. Labeling capsids should have the advantage of minimal (if
any) perturbation of the lambda lysis-lysogeny decision. However, such a system also has
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possible drawbacks. First, phage capsids may be empty (Ian Molineux, pers.comm.); empty
capsids would therefore need to be removed by phage puriﬁcation prior to labeling [63].
Second, not all phage bound to cells eject their DNA [112]. For maximum accuracy in
determining MOI, a system based on enumerating capsid would need to be used alongside
a system to detect phage DNA ejection. Third, it is unclear whether two phage particles
bound near one another could be reliably resolved, especially if the individual particles do
not change relative position on the cell surface over time.
6.1.1 Labeling phage capsids with Quantum Dots
I initially considered labeling phage capsids using quantum dots (Qdots), which are ﬂuo-
rescent semiconductor nanocrystals [122]. Methods to bind Qdots to bind to phage have
been published [43, 44]. However, the authors were only able to label ∼80% of phage [44],
making this method unsuitable for accurate determination of MOI.
6.1.2 Labeling phage capsids with ﬂuorescent proteins
I tested the lambda strain λ D-eyfp cI857 Sam7 constructed in the laboratory of Phillippe
Thomen [10]. In this strain, the enhanced yellow ﬂuorescent protein (EYFP) is attached to
the C terminus of the minor lambda capsid protein D via a GL(GSGG)3TA linker. There
are typically 405-420 D proteins per capsid [63]. The GL(GSGG)3TA linker has been used
by other researchers for fusing D to diﬀerent proteins, and was found not to interfere with
binding of D to the lambda capsid [179].
I grew host cells to exponential phase in M9GlyMMC (M9 [151] supplemented with 0.4%
glycerol, 0.4% maltose, 10mM MgSO4 and 0.1% casamino acids). Cells were resuspended
in TM [63] and infected with λ D-eyfp cI857. Infected cells were placed on 2% agarose
pads supplemented with M9GlyMMC. I made time-lapse movies of infection, taking phase
contrast and YFP ﬂuorescence pictures every ∼15min.
Infected cells which became lytic were easily detected by ﬂuorescence microscopy due to
the production of D-EYFP during the late lytic stage of infection. However, I did not detect
yellow ﬂuorescent foci on the surface of the majority of infected cells (see Figure 6-1, bottom
ﬁlmstrip for an example). The absence of ﬂuorescent foci at the beginning of infection was
not due to a mutation in eyfp, because infected cells produced ﬂuorescence (presumably
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Figure 6-1: Infection of MG1655 with λ D-eyfp cI857 Sam7. MG1655 was
grown in M9GlyM and infected at an average API of ∼0.5 with λD-eyfp cI857 Sam7.
Time-lapse movies were made as described earlier. The top ﬁlmstrip shows a bacterial
cell apparently infected (ﬂuorescent focus at one pole). A second ﬂuorescent focus
is also seen in the top right corner of each image, but does not seem to be attached
to the cell. Fluorescence is observed inside the cell from t=33 min, presumably from
production of D-EYFP protein. The cell lyses between t=57 and t=59 min. The
bottom ﬁlmstrip shows a cell which initially does not appear infected (no ﬂuorescent
focus seen near the cell). However, from t=35 min, ﬂuorescence is produced from
t=35 min and the cell ultimately lysis between t=73 and t=75 min.
from D-EYFP) prior to lysis. To test if the absence of foci may be due to poor maturation
of the EYFP in my conditions, I incubated my phage stock at room temperature with
aeration for several hours prior to infection. However, this procedure did not qualitatively
increase the number of infected cells detected using the D-EYFP fusion.
My results suggest the presence in my phage stocks of a large number of non-ﬂuorescent
phage capsids, perhaps because they contained fewer D proteins than wild-type phage, or
because the linker between D and EYFP was cleaved during capsid formation. Cleavage
of diﬀerent linkers between D capsid and fusion proteins has been reported for fusions
between D and other proteins [180], and is thus a plausible explanation. This issue cannot
be remedied by creating fusions to D without the use of linkers, because both termini of
protein D are located in the interface between D and the rest of the capsid [179]; linkers are
therefore necessary to allow the fused portion to reach the outside of the capsid. Linkers
known to better resist proteolytic cleavage — for example, PT linkers [78] — are less ﬂexible
and therefore likely to perturb the interface between D and the rest of the capsid, thereby
interfering with capsid formation. Fusions to other phage capsid proteins might work but
were not attempted.
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Figure 6-2: Cy3-labed phage lambda particles. Puriﬁed phage lambda particles
were puriﬁed and labeled using the cyanide-based dye Cy3 as described [59], with the
exception that I used Cy3 instead of Cy5. Labeled phage were placed on 2% agarose
pads in TM [63], and imaged using a GFP ﬁlter set and a ∼200ms exposure time.
Individual foci may be single phage particles.
6.1.3 Labeling phage capsid with chemical dyes
An alternative to using genetic fusions of ﬂuorescent proteins to capsid proteins is to stain
capsid proteins using chemicals. For example, CyDyes NHS Esters (GE Healthcare) have
been previously used by the Phillips lab at Caltech to stain lambda capsid proteins [59].
These ﬂuorescent dyes of the cyanine family react with exposed amine, forming covalent
adducts.
I puriﬁed, stained and visualized stocks of wild-type lambda particles as described pre-
viously [59]. While staining resulted in reasonably ﬂuorescent particles (Figure 6-2, p.96),
I was unable to ﬁnd ﬂuorescent foci adsorbed onto cells, and time-lapse movies of infection
showed no infection. Possibly CyDye formed adducts with the J protein of the lambda tail,
thereby interfering with binding of lambda onto its cognate receptor, LamB [139, 165]. To
test this hypothesis, I divided a common phage stock into two fractions which were treated
identically, with the exception that one fraction was labeled in Cy3 and another was not
labeled. I found that Cy3 labeling resulted in a > 500-fold reduction of in titer, presumably
by interfering with adsorption, so I abandoned this line of work.
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6.2 Quantiﬁcation of the MOI by labeling phage
DNA
A diﬀerent set of methods to determine the multiplicity of infection (MOI) could rely on the
detection and enumeration of phage genomes following their entry into host cells. Unlike the
methods presented in the previous section, direct detection of phage DNA is not complicated
by the possible presence of empty phage capsids and of phage which did not eject their DNA.
However, the systems described below have a greater probability of interfering with phage
development (e.g. replication, transcription). I considered the following two methods:
1. Labeling phage DNA using ﬂuorescent repressor-operator systems (FROS) (see sec-
tion 6.2.1 below)
2. Labeling phage DNA using ParB-parS systems (see section 6.2.2, p.99)
6.2.1 Labeling phage DNA using the FROS system
I tested the use of ﬂuorescent repressor operator systems (FROS). In these systems, a DNA
segment — typically containing 64-240 lac or tet operators (lacO, tetO) — is introduced in
the desired DNA locus. When in the presence of fusions of the operators’ cognate binding
proteins fused to GFP (i.e. LacI-GFP or TetR-GFP), a ﬂuorescent focus can be seen using
a ﬂuorescent microscope [97, 144]. I introduced a cassette of (a) 120 lac operators and a
kanamycin marker or (b) 120 tet operators and a gentamycin marker into the b region of a
wild-type phage lambda using recombineering [167]. A [lacO]120-kanR array (5313bp) was
PCR-ampliﬁed from pLau43 [97] using the following primers:
• Forward primer:
5’-acggcatccacgaaggcgacagaggctgcgggaagtgcggtatcagcatc
CTATGACCATGATTACGAATTC-3’
• Reverse primer:
5’-gtggcgtacagtcatagatggtcggtgggaggtggtacaaattctctcat
CTATGACCATGATTACGAATTC-3’
Sequences in capital letters are those homologous to the plasmid containing the ar-
ray, while those in small letters are homologous to lambda’s b region, replacing sequences
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between lambda coordinates 20620 and 24268. The [tetO]120-gentR array (4931bp) was
PCR-ampliﬁed from pLau44 [97] using the following primers:
• Forward primer:
5’-acggcatccacgaaggcgacagaggctgcgggaagtgcggtatcagcatc
CTAGATTAGGTGGCGGTACTTGGG-3’
• Reverse primer:
5’-gtggcgtacagtcatagatggtcggtgggaggtggtacaaattctctcat
CTATGACCATGATTACGAATTC-3’
Recombinants λ b::[lacO]120-kanR or λ b::[tetO]120-gentR were selected as described in
Chapter 2 (for the TetO arrays, I used 15μg/ml gentamycin), and conﬁrmed by PCR. λ
b::[lacO]120-kanR and λ b::[tetO]120-gentR strains have genomes 3% and 2.2% greater than
wild-type, respectively. Genome length no greater than ∼5% of wild-type length can be
eﬃciently packaged [47].
I transformed MG1655 with plasmids expressing LacI and/or TetR fused to ﬂuorescent
proteins, under the control of a weak constitutive promoter [171,172]:
• pWX6 expresses LacI-CFP and TetR-YFP;
• pWX18 expresses LacI-CFP
I resuspended the resulting cells to OD600∼2.0 in TM [63], added phage at average MOI
of ∼2 and incubated at 4℃ for 30 min for adsorption to occur. Free phage were removed
by centrifugation and infected cells were placed on a 2% LMP agarose supplemented with
TM. Infected cells were then imaged by ﬂuorescent microscopy.
Only a few weak ﬂuorescent foci were visible following infection with λ b::[lacO]120-kanR
(Figure 6-3b,c; p.99), while foci from λ b::[tetO]120-gentR were easily visible (Figure 6-3a).
Using PCR, I found this was because the lacO array of most phage of my various stocks of
λ b::[lacO]120-kanR had shrunk drastically, thereby reducing the number of binding sites for
LacI-GFP (data not shown). This result was unexpected, because the LacI binding sites in
these arrays were separated by random sequences to minimize recombination and thereby
shrinking/expansion of the arrays [97]. Array size modiﬁcations were found to occur while
amplifying phage to make phage stocks. Using a recA− strain as host for making phage
stocks did not eliminate the problem (data not shown).
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Figure 6-3: Infection of MG1655 with λ b::[lacO]120-kanR and λ b::[tetO]120-
gentR. a, MG1655/pWX6 infected with λ b::[tetO]120-gentR. b, MG1655/pWX6
infected with λ b::[lacO]120-kanR. c, MG1655/pWX18 infected with λ b::[lacO]120-
kanR. Arrows indicate faint foci.
Shrinking of tetO arrays was also observed, but to a lesser extent (data not shown).
However, I found that the tetO array appeared to block normal replication of the phage
(6-4, ﬁrst two columns). Wang and colleagues had observed some block of replication
when lacO or tetO arrays were used on the chromosome, and found that addition of low
concentrations of the cognate inducer (IPTG for lacO arrays; anhydrotetracycline (aTc)
for tetO arrays) eliminated replication blocks [172]. Unfortunately, addition of aTc at the
suggested concentration (40 ng/ml) also elimininated foci formation (Figure 6-5,p.101). In
light of these problems, I shifted my research focus to ParB/parS systems (next).
6.2.2 Labeling phage DNA using ParB/parS systems
Another system to label DNA loci is based on the partition protein ParB, which can spread
along the DNA from a nucleation site, the ∼25bp parS DNA sequence [148]. When fusions
of ParB and GFP are expressed in a cell containing a parS sequence, GFP ﬂuorescent foci
can be observed in the location of the parS sequence [102,103]. Because of a deletion of 30
amino acids, the ParB proteins using in these systems cannot function as partition proteins,
but they are still able to bind to their cognate parS (and subsequently spread to neighboring
sequences) [102]. There exist ParB/parS of diﬀerent speciﬁcities, one from phage P1 and
one from plasmid pMT1. ParB proteins of the opposite speciﬁcities do not cross react with
parS sequences of the opposite speciﬁcity [126].
I set out to test whether the ParB/parS system can be used to count individual phage
genomes in infected cells. I introduced the P1parS-kanR cassette into the b region of a wild-
99
238
73
113
158
193
a  b  c
Figure 6-4: tetO arrays may interfere with phage DNA replication.
MG1655/pWX6 was infected with λ b::[tetO]120-gentR at a population-average MOI
of ∼2. Infected cells were placed on 2% LMP agarose pads supplemented with
M9GlyMMC. Growth at 30℃ was monitored, taking both phase contrast and ﬂuores-
cent pictures. a, An infected cells displays two ﬂuorescent foci, perhaps corresponding
to two individual phage particles. Lambda may have chosen the lysogeny pathway in
this cell, given that the cell survives and divides. However, even after a few rounds
of division, no increases in the number of ﬂuorescent foci are seen (compare with c).
b, One ﬂuorescent focus is seen in the infected cell in the middle of the ﬁeld. The
putative phage particle does not appear to replicate (no additional foci are observed)
prior to lysis on the fourth frame. c, A cell displays two foci which replicate, giving
rise to at least 8 foci on the last frame. I do not know why replication was observed
in some cells (ﬁlmstrip c) but not others (ﬁlmstrips a,b). Arrows indicate foci, which
are sometimes diﬃcult to see on the illustration.
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Figure 6-5: Eﬀect of anhydrotetracycline (aTc) on ﬂuorescent foci formation
following infection of MG1655 with λ b::[tetO]120-gentR. MG1655/pWX6 was
infected with and was grown on M9GlyMMC alone (a) or supplemented with 40ng/ml
aTc (b).
type phage lambda. I ﬁrst ampliﬁed the cassette from pALA1073 [102] using the following
primers:
• Forward primer:
5’- aggcagcaaaatcatcagaaacgaacgcatcatcaagtgccggtcgtgca
CACAGCTTTAGAGCGTTTTGCGAT -3’
• Reverse primer:
5’- ccgtatccttcacccaggctgtgccgttccacttctgatattcccctcc
CGATAAAAAGCCGAAGCCTTAAAC -3’
Sequences in capital letters are those homologous to the plasmid containing the cassette,
while those in small letters are homologous to lambda’s b region. The resulting phage, λ
b::P1parS-kanR, has the 1,563 nt P1parS-kanR cassette replacing lambda coordinates 20430
and 22278. The newly constructed phage has 286 nt (∼0.6%) fewer nucleotides than wild-
type lambda, and should therefore show no decrease in packaging eﬃciency [47]. Aam19
and cI857 alleles were introduced by recombineering as described in Chapter 3.
I used the resulting phage, λ Aam19 b::P1parS-kanR cI857, to infect MG1655 expressing
ParB-GFP from pALA2705 [102]. Fluorescent foci could be detected (Figure 6-6, 102).
Experiments are underway to determine to what extent the ParB/parS system can be used
as reporter of MOI.
101
Figure 6-6: Infection of MG1655 with λ b::P1parS-kanR. MG1655 harboring
a P1ParB-GFP expression plasmid (pALA2075, [102]) was grown in M9GlyMMC
+ 50ug/ml carbenicillin. The culture was grown at 30℃ with vigorous agitation
to OD600∼0.05. IPTG (100μM) was added to the medium and cells grown for an
additional hour. Cells were infected with λ b::P1parS -kanR at a population-average
MOI of ∼2. Cells were placed on 2% LMP agarose supplemented with M9GlyMMC.
Phase contrast and ﬂuorescent images were taken periodically at 30℃. For both cells,
ﬂuorescence appears to spread over a larger area over time, possibly corresponding
to replication of the phage DNA.
6.3 Chapter summary
I tested several systems as potential reporters of the multiplicity of infection (MOI). Labeling
phage capsid using ﬂuorescent proteins resulted in a large fraction of phage not exhibiting
detectable ﬂuorescence, possibly because of cleavage of the linker separating the capsid
protein (D) from the ﬂuorescent protein (EYFP). Labeling phage capsid with chemical dyes
resulted in inactivation of lambda particles, possibly because the dyes interfered with the
binding of lambda onto its receptor (LamB). Labeling of phage DNA using the FROS system
appeared to interfere with phage replication. Also, the tetO and lacO arrays were found to
shrink during formation of my phage stocks, resulting in lambda particles exhibiting little
or no ﬂuorescence. Labeling of the phage DNA using the ParB/parS system is currently
under evaluation.
6.4 Chapter acknowledgments
• Arun Devabhaktuni (Endy lab) tested λ D-eyfp cI857 Sam7 (Section 6.1.2, p.94) as a
reporter of MOI and constructed λ Aam19 b::P1parS-kanR cI857 (see Section 6.2.2,
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• Tony Kuzhippala (Endy lab) performed the experiments with chemical labeling of the
phage capsid (Section 6.1.3, p.96), and initial attempts at recombineering the tetO
and lacO arrays onto phage lambda (Section 6.2.1, p.97).
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Chapter 7
Conclusion
It has been known for over 55 years that apparently homogeneous cultures of Escherichia
coli cells can bifurcate into two populations following infection by phage lambda: some cells
become lytic, while others survive as lysogens [104]. Lieb, Gros and Kourilsky suggested
that variation in the lysis-lysogeny decision may result from cell-cell variability present prior
to infection [94, 104]. More recently, Arkin, Ross, and McAdams proposed an alternative
explanation whereby spontaneous chemical "noise" in lambda gene expression creates vari-
ability in the fate of infected cells [13]. In this thesis, my primary aim has been to determine
whether and to what extent variation in cell fate selection results from pre-existing phe-
notypic cell-cell diﬀerences (1-6b, p.31), rather than chance events during infection (1-6a,
p.31).
In considering possible deterministic inﬂuences on the lambda lysis-lysogeny decision, I
selected host volume as a possible marker of cell fate (Section 2.1, p.35). My results show
that the fate of individual lambda-infected cells is strongly correlated with pre-existing
variation in host volume. For example, a ∼2-fold increase in the size of stationary phase
cells led to a ∼5-fold decrease (61% to 12.2%) in frequency of lysogeny (Figure 3-2,p.67). I
initially observed that lambda was sensitive to host volume using elutriation as a method
for segregating larger and smaller cells, and macroscopic plate tests (plaques, colonies) for
determining cell fate (Figure 2-11, p.54). My initial ﬁnding was conﬁrmed at the single-cell
level using time-lapse ﬂuorescent microscopy. I observed that the frequency of lysogeny
decreased with increased cell size in two conditions, which diﬀered from one another with
respect to strain genotypes, culture medium and growth phase (Figure 3-2, p.67 and Figure
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4-3, p.75). I also found no correlation between cell volume and the activity of a represen-
tative endogenous stationary phase promoter, as expected if the sensitivity to cell volume
is not speciﬁc to stationary phase (Section 4.1.2, p.75). Sensitivity to pre-existing variation
in host volume may thus be a general feature of the lysis-lysogeny regulatory network of
phage lambda.
My ﬁndings challenge the view that diﬀerences in lambda cell fate outcomes are solely
driven by intrinsic noise during infection. The lambda regulatory network is not only
composed of phage-encoded components; rather, it operates within a bacterial environment
that can also exhibit variation. Future biophysical models of lambda cell fate selection
might do well to represent such variation.
The correlation between the size and fate of lambda-infected cells is particularly strong
considering the limitations of the methods I used to observe and analyze the lysis-lysogeny
decision. For instance, the size measurements of individual cells of Figure 3-2 (p.67) and
Figure 4-3 (p.75) were made manually, considered variation in cell length only, and repre-
sented the size of cells at the start of imaging rather than at some critical time window
during infection when the lysis-lysogeny decision is being set.
7.1 How does host volume impact lambda devel-
opment?
Preliminary evidence presented in Section 5.4 (p.89) suggests that host volume (or a corre-
lated variable) is likely to impact the lambda regulatory circuit upstream of (or at the level
of) CII activity. However, there are still many known molecular mechanisms that could
point towards a model for explaining how preexisting variation in cell volume set the level
and activity of CII.
One such model is the “gene dosage” model introduced in Section 2.1 (p.35). In the
conditions used for my experiments, ∼2-fold diﬀerences in volume produced 4-5 fold change
in the frequency of lysogeny. One prediction of the gene dosage model is therefore that
lambda decision circuit should be sensitive to relatively small (∼2 fold) variation in the con-
centration of one or more phage-encoded genes. I could test this prediction by determining
whether and to what extent phage with diﬀerent mutations can stimulate lysogenization by
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a wild-type lambda particle. For example, I would infect cells with two phage strains at
relatively low phage:cell ratio:
• λ Aam19 b::GFP cI857
• λ Aam19 b::RFP cI857 with either no additional mutations (“wild-type”), or with
mutations in key regulators of the lysis-lysogeny decision (e.g. cII−, cIII−).
Let’s assume the expression level of a given gene — cIII for the purpose of this example
— is limiting for lysogeny. If true, I would expect that coinfection with λ Aam19 b::GFP
cI857 and λ Aam19 b::RFP cI857 should result in higher frequencies of lysogeny than
coinfection with λ Aam19 b::GFP cI857 and λ Aam19 b::RFP cI857 cIII−. These proposed
experiments are the single-cell equivalent of experiments performed by Kourilsky, Kaiser
and Reichardt [93,142,143].
There are other models than “gene dosage” that might account for the observed cor-
relation between host volume and cell fate. For example, this correlation could also be
due to physiological diﬀerences between smaller and larger cells, possibly because of their
presumably distinct positions within the cell cycle. As a result, variation in volume may
correlate with diﬀerences in the amount, localization or activity of host-encoded regulators
of lambda development such as HﬂB/FtsH or RNaseIII [67,87,89,138,173,178]. Eﬀorts are
underway to use septation mutants to decouple cell cycle position from cell volume (Section
4.2, p.81)
7.2 Is the lambda lysis-lysogeny decision completely
deterministic?
While host size prior to infection is a strong predictor of cell fate, it appears that the lambda
cell fate selection process may still be sensitive, in part, to other types of variation, including
variation during infection. For example, Figure 3-2 (p.67) and Figure 4-3 (p.75) show that
there is no “critical” volume above or below which all infected cells produce an identical
developmental response.
In addition, a small number of infected cells (1.6-5.1%) divide and give rise to two
daughters who obtain disparate cell fates, one that undergoes lysis and another that con-
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tinues to grow and divide (Figure 3-1, p.66; Figure 4-2, p.74). If host size immediately prior
to infection completely determined cell fate, I would expect the developmental response of
daughter cells to be identical. Thus, mixed fate outcomes might represent an ideal case of
intrinsic noise in gene expression or in partitioning of molecules (protein, DNA, mRNA)
between daughter cells during cell division. Alternatively, mixed fate outcomes may still
represent a deterministic process: for instance, the “age” of the poles (and other diﬀerences)
of the two daughter cells might diﬀer and aﬀect cell fate selection following division of the
originally infected cell [128]. It will be exciting to explore further if the lysis-lysogeny de-
cision is absolutely determined by cell-cell variation present prior to infection (1-6b, p.31),
or if lambda might “play dice” to some degree or on rare occasions (1-6a, p.31). It would
also be interesting to ﬁnd out whether the lysis-lysogeny decision of other temperate phage
is similarly aﬀected by pre-existing cellular phenotypic variation.
7.3 Why might lambda developmental outcome be
correlated with host volume?
More generally, the sensitivity of lambda infection to preexisting physical variation high-
lights an opportunity to study how evolution shapes or delimits the molecular mechanisms
underlying the behavior of biological systems. One possibility is that cell-cell variation in
volume reﬂects physiological diﬀerences that lambda must sample to make optimal devel-
opmental decisions at the single cell level. For example, the lytic response may be preferred
in infected cells capable of producing a large burst of progeny phage. Because larger cells
presumably contain more material (amino acids, nucleotides, etc.) than smaller cells, they
may produce greater bursts of phage particles. Alternatively, the response to pre-existing
variation in host size may be an artifact of circuitry selected to be responsive to other, more
dominant factors. For example, lambda’s regulatory network may be tuned to respond to
the MOI by measuring the concentration (rather than the absolute number per se) of phage
infecting a given cell. If true, lambda would not be able to distinguish between variations
in phage concentration due to diﬀerences in MOI or in host volume.
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7.4 Cell fate selections in other biological model
systems
Regardless of the molecular mechanism through which the lambda cell fate selection process
responds to extrinsic variation, it is interesting to consider the extent to which other cell
fate decisions may be predetermined. In particular, the lysis-lysogeny regulatory network
of other temperate bacteriophage — such as P22, P2, HK022 and TP901-1 — are known
to exhibit similarities to lambda’s decision circuitry [25, 40, 63, 134]. The Salmonella ty-
phimurium P22 is also known to respond to some of the same environmental parameters
as lambda: for example, higher numbers of phage per cell enhances lysogenization [24,100].
It would be valuable to determine whether a correlation between host volume and cell fate
is also present in P22 and other temperate phage. The observation of such a correlation
would suggest that cell size (or a correlated variable) is not simply an idiosyncrasy preserved
during evolution by the particular ecology of lambda’s natural habitat. If not all temperate
phage exhibit an apparent sensitivity to host volume, an important challenge would be to
understand why such a sensitivity has been selected during the evolution of only certain
phage. In either case, comparing the regulatory networks of lambda and other temperate
phage may help unraveling the molecular mechanism by which lambda appears to sense and
respond to cell-cell variation in volume.
Another cell fate decision which has attracted renewed attention in recent years is the
reversible entry into a state of competence for DNA uptake by a fraction of Bacillus subtilis
cells following entry into stationary phase. Evidence is accumulating that noise intrinsic to
the expression of ComK, a transcription factor necessary and suﬃcient for for diﬀerentiation
into competence, may explain why not all cells become competent [111, 160, 161]. Indeed,
reduction of comK gene expression noise by two diﬀerent methods resulted in a lowered
frequency of entry into competence [111, 161]. Variability in cell size does not appear to
impact entry into competence (G. Suel, pers. comm.). Nevertheless, entry into competence
might still determined, in part, by pre-existing cell-cell diﬀerences which have not been
investigated so far. Deterministic parameters might impact the fate of B. subtilis by tuning
the amount of noise in individual cells. However, such putative cell-cell diﬀerences would
not be heritable, as sister cells are no were more or less likely to become competent if their
sister became competent [160]. It will be exciting to ﬁnd out whether the impact of pre-
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existing variation on cell fate selection might depend on whether the resulting diﬀerentiation
is transient (e.g. entry of B. subtilis cells into a state of competence) or largely permanent
(e.g. the lambda lysis-lysogeny decision).
Consideration of deterministic and stochastic inﬂuences on diﬀerentiation is also impor-
tant in understanding eukaryotic cell fate decisions, such as diﬀerentiation of stem cells. In
particular, diﬀerentiation of haematopoietic stem cells is a well-studied paradigm for lineage
commitment [45]. In a deterministic or “instructive” model, external factors controll cell
fate choices, while in stochastic or “selective” models, external factors simply allow growth
and survival of cells which, by chance, were already committed to a speciﬁc lineage. Un-
covering deterministic cues are clearly important for medical applications, for example by
allowing control over lineage commitment. Some evidence suggests that apparently stochas-
tic variation in expression of lineage-speciﬁc transcription factors can prime haematopoietic
stem cells for diﬀerent fates [26, 45, 118]. However, it is unclear whether such spontaneous
variation plays a major role in lineage commitment of stem cells in their natural context
i.e. within individual animals.
Since the publication of the Arkin model [13], several hundred reports have discussed the
importance of stochastic variation in gene expression and other cellular processes (e.g., [27,
141,157]). It will be interesting to ﬁnd out whether stochastic variation during development
actually impacts the outcome of many cell fate decisions. For comparison, development
can often be predictable: for example, the patterns of programmed death and terminal
diﬀerentiation during embryonic development of Caenorhabditis elegans are nearly invariant
from one individual to the next [162]. Understanding how and the extent to which natural
biological systems tolerate, buﬀer or correct for spontaneous molecular variation during
development in order to produce deterministic behavior deserves more attention [12,70,71,
114,125,140].
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